FINISH - The Michael J. Fox Foundation for Parkinson's ...

44
FINISH PROGRESS MIDYEAR REPORT 2011 | ANNUAL REPORT 2010

Transcript of FINISH - The Michael J. Fox Foundation for Parkinson's ...

FINISH

Progressmidyear report 2011 | annual report 2010

2 m

idye

ar r

epo

rt 2

011

| an

nu

al r

epo

rt 2

010

tHe micHael J. Fox Foundation is dedicated to Finding a cure For parkinson’s disease

tHrougH an aggressively Funded researcH agenda and to ensuring tHe development

oF improved tHerapies For tHose living witH parkinson’s today.

2 LetterFromtheCEO,Founderand Co-Founder&ExecutiveViceChairman

4 ScientificProgressReport Leading on Biomarkers/PPMI

Increasing Participation in Clinical Trials

Accelerating LRRK2 Therapeutic Development

Driving New Treatments for Dyskinesia

Repositioning Existing Drugs

14 2010inPhotos

16 2010DonorListing

34 FinancialHighlights

Progressmidyear report 2011 | annual report 2010

2 m

idye

ar r

epo

rt 2

011

| an

nu

al r

epo

rt 2

010

In the past 18 months, across our broad

portfolio of activities, we have embarked on an

ambitious set of initiatives that offer new and

groundbreaking opportunities for the patient

and research communities to come together and

be part of the momentum we’re building in our

urgent pursuit of a Parkinson’s cure.

The Foundation is now approaching $300

million in research funded — all for projects

targeted to push the most promising therapeutic

breakthroughs closer to pharmacy shelves. In

2010, we received nearly 65,000 contributions

and reviewed over 600 PD-specific grants from

research teams all over the world. Our in-

house staff of PhDs and business strategists

worked directly with hundreds of researchers

and clinicians from academia and industry to

manage our portfolio of over 300 active grants.

In our short history we have earned tremendous

credibility with the research community. And

today we can say with confidence that the model

we have built is speeding progress:

● We have enabled outcomes-focused work

on over 100 therapeutic targets and invested

more than $100 million in the development of

disease-modifying therapies. On the back of this

investment, we have identified and advanced

several leading targets — including genetic

targets LRRK2 and alpha-synuclein as well as

dopamine-protecting neurotrophic factors —

for prioritized action.

LetterfromtheCEO,FounderandCo-Founder&ExecutiveViceChairman

● Building on significant and systematic

biomarker investments of $28 million from 2002–

2010, our landmark $45-million biomarker study,

the Parkinson’s Progression Markers Initiative, is

now under way and enrolling PD patients and

controls in 21 sites in the United States and

Europe, with nine industry funding partners in

place and expansion to Australia in the offing

for 2012.

● MJFF funding since 2005 has validated no

fewer than five promising drug targets for

dyskinesia — the debilitating side effect of long-

term dopamine replacement — with two already

in clinical testing and the remainder advancing

there rapidly.

● The Foundation has forged paradigm-shifting

processes for developing critical research tools

and then distributing them at low or no cost to

academic and industry researchers — including

pre-clinical models and basic laboratory reagents

that allow scientists to efficiently study cellular

functions at work in Parkinson’s pathology and

test new treatment approaches.

● We are now seeing greater than ever interest

and investment in PD by industry players —

from small and midsized biotechs to the giants

of Big Pharma — whose resources, expertise

and business incentive are non-negotiable

requirements to take promising new treatments

through clinical testing and regulatory approval.

WhenthecureforParkinson’sdiseaseisfound,andthestoryofTheMichaelJ.FoxFoundationwritten,theyears2010and2011willsurelymarkthebeginningofanewchapterinthenarrative.

3 letter

Fro

m tH

e ceo

, Fou

nd

er an

d c

oFo

un

der

& exec

utive vic

e cH

airm

an

Throughout this report, you’ll read about the

strategic roadmap developed by MJFF to

orchestrate and streamline Parkinson’s

therapeutic development, providing both financial

and intellectual leadership that has galvanized

the field and moved us tangibly closer to definitive

clinical trials and breakthrough treatments.

This is exciting. Yet it also poses new challenges

for our problem-solving, which we are meeting

head-on with fresh, collaborative platforms

designed to inspire the Parkinson’s community

— and the general public — to action in greater

numbers than ever:

● As resource-intensive as pre-clinical research is,

the clinical projects we see on the horizon come

with exponentially steeper price tags. The Brin

Wojcicki Challenge creates a critical opportunity

for the Foundation to double the capacity-building

funds (up to $50 million) we can raise by the end of

2012. With your help in earning match dollars, we

will ensure that no promising clinical study goes

unfunded due to lack of resources.

● Underenrollment in clinical research, by

people both with and without PD, slows research

progress — and we all pay the price in terms of

higher costs and longer time horizons to treatment

breakthroughs. The Foundation has stepped up to

answer this challenge with the development of a

new Web-based tool, Fox Trial Finder, a smart and

user-friendly solution to connect willing volunteers

with the specific trials that need them.

● Our grassroots fundraising network, Team

Fox, has grown exponentially since its founding

in 2006. With more than $15 million raised, this

group remains the passionate standard-bearer

for our message of can-do optimism and action

across the country and around the world — and

its numbers only continue to increase.

No doubt the road ahead remains challenging,

but we are gaining real traction. We know we are

on track to achieve our shared goal of eradicating

Parkinson’s disease. Thank you, as always, for your

vital support.

Todd Sherer

CEO

Michael J. Fox

Founder

Deborah W. Brooks

Co-Founder & Executive Vice Chairman

4 m

idye

ar r

epo

rt 2

011

| an

nu

al r

epo

rt 2

010

LeadingonBiomarkers/PPMI1

BIOMARKERSThere are no biomarkers for Parkinson’s disease, meaning drugmakers don’t know whether the drugs they are testing actually work. The Michael J. Fox Foundation sponsored Parkinson’s Progression Markers Initiative exists to identify biomarkers, putting lines on the playing field in order to develop new and better treatments for PD.

+ =

BIOMARKERSThere are no biomarkers for

Parkinson’s disease, meaning

drugmakers don’t know whether the

drugs they are testing actually work.

The Michael J. Fox Foundation-

sponsored Parkinson’s Progression

Markers Initiative exists to identify

biomarkers, putting lines on the

playing field in order to develop new

and better treatments for PD.

+ =

THE FOX EFFECTIdentification of a drug target typically

unfolds in an uncoordinated way as

different labs analyze it from discrete

angles, often at the expense of

opportunities for collaboration. MJFF is

orchestrating efforts to encourage

sharing data and resources early in the

process so that LRRK2 can evolve

toward practical drug therapy faster.

DYSKINESIAA debilitating side effect of current “gold –standard”

treatment for PD, dyskinesia is difficult to study

because it varies in intensity, frequency and duration.

MJFF is pushing dyskinesia treatments toward

patients by working on biomarkers, new drugs and

drug targets and clinical scales simultaneously to

optimize dyskinesia clinical trials. There is great

optimism in the PD scientific community that we will

see successful dyskinesia treatments come to market

in the relatively near future. 1 = 60 months

= 20 months

= 12 months

= 8.6 months

= 6.7 months

3

5

7

9

CLINICAL TRIALSThe serious shortage of participants

in clinical research impedes

therapeutic progress and creates a

tremendous financial burden as trial

timelines expand. The trial in this

example requires 60 patients. The

more patients recruited per month,

the quicker the results and at a

lesser cost.

= 2.4 months25

Total Expenses

$ $ $ $ $ $ $ $

$ $ $ $ $ $ $

$ $ $ $ $ $

$ $ $ $ $

$ $ $ $

The Michael J. Fox Foundation created the Fox Trial Finder tool (www.foxtrialfinder.org) to streamline the flow of volunteers into trials.

By taking a drug already

known to be effective for

another disease and testing it

against Parkinson’s disease,

clinical testing in Parkinson’s

patients can begin much

faster than traditional

therapeutic development

would allow. This means a

treatment can arrive on

pharmacy shelves sooner.

5 sc

ientiFic

pro

gr

ess repo

rt

“The role of The Michael J. Fox Foundation in conceiving PPMI and shaping its course has been extremely innovative. It’s truly impressive how the Foundation has brought the community together and Pfizer is proud to be part of it.”John Dunlop, PhD, Pfizer, Inc.

In2010TheMichaelJ.FoxFoundationlaunchedthefive-year,$45-millionParkinson’sProgressionMarkersInitiative(PPMI),agroundbreakinglongitudinalstudytovalidatebiomarkersofParkinson’sdisease.BiomarkersarecharacteristicsthatcanbemeasuredandevaluatedobjectivelytodiagnoseParkinson’s

earlier,providecleareroutcomesfromclinicaltrialsandlowerthehurdletoindustryinvestmentinPD.PPMIbringsfullcircleMJFF’sinvestmentsof$28millioninbiomarkerdiscoveryfrom2002to2010.Thestudyis

nowunderway,enrolling400Parkinson’spatientsand200controlvolunteersin21sitesintheUnitedStatesandEurope,andwillexpandtoAustraliain2012;itisfundedbyMJFFinconjunctionwithaconsortiumofindustrypartners(seepage16).

Parkinson’s patients have access only to treatments that

temporarily alleviate symptoms. If a biomarker is found through

PPMI, researchers will have a critical tool to use in the quest

for disease-modifying therapies that can slow or stop the

progression of the disease. The existence of a biomarker would

de-risk PD drug development by increasing the certainty

of research results, likely enabling smaller, shorter, more

predictable and potentially less expensive clinical trials.

Yet the development of reliable and valid measures of PD

requires such a major systematic infrastructure investment

that no single company has the incentive to do it alone.

By establishing a consortium of industry partners to help

fund the study, PPMI offers companies the opportunity

to help move the field forward while taking on only a

fraction of the risk.

PPMI exemplifies MJFF’s commitment to streamlining

the scientific process, increasing collaboration/data-

sharing, and putting resources where other funders

can’t or won’t in order to speed life-transforming

treatments to patients.

BIOMARKERSThere are no biomarkers for Parkinson’s disease, meaning drugmakers don’t know whether the drugs they are testing actually work. The Michael J. Fox Foundation sponsored Parkinson’s Progression Markers Initiative exists to identify biomarkers, putting lines on the playing field in order to develop new and better treatments for PD.

+ =

6 m

idye

ar r

epo

rt 2

011

| an

nu

al r

epo

rt 2

010

IncreasingParticipationinClinicalTrials

2

1 = 60 months

= 20 months

= 12 months

= 8.6 months

= 6.7 months

3

5

7

9

CLINICAL TRIALS

The serious shortage of participants

in clinical research impedes

therapeutic progress and creates a

tremendous financial burden as trial

timelines expand. The trial in this

example requires 60 patients. The

more patients recruited per month,

the quicker the results and at a

lesser cost.

= 2.4 months25

Total Expenses

$ $ $ $ $ $ $ $

$ $ $ $ $ $ $

$ $ $ $ $ $

$ $ $ $ $

$ $ $ $

The Michael J. Fox Foundation created the Fox Trial Finder tool (www.foxtrialfinder.org) to streamline the flow of volunteers into trials.

7 sc

ientiFic

pro

gr

ess repo

rt

AstheU.S.populationages,thenumberofindividualsaffectedbyParkinson’sdiseasewillonlygrow.AccordingtoarecentWall Street Journalopinion

piecebyNobellaureateStanleyPrusinerandformerSecretaryofStateGeorgeShultz,threeoutoffiveAmericanswillsufferfromanervous-systemdiseasesuchasParkinson’sorAlzheimer’s.

Clearly, the need for high-impact investment in research has

never been more urgent. But while financial investment is

critical, dollars alone will not take us across the finish line in

pursuit of therapeutic breakthroughs. The active involvement

of Parkinson’s patients and their loved ones in clinical research

is vital to finding the cure. Yet today, as many as 80 percent of

clinical trials face recruitment challenges, which significantly

increase costs and delay progress toward breakthroughs.

In summer 2011, MJFF launched Fox Trial Finder

(www.foxtrialfinder.org), a simple Web-based solution to

address these challenges head-on. With the single-minded

goal of bringing more willing volunteers to the PD clinical trials

that urgently need them, Fox Trial Finder combines robust

and relevant content — the Foundation is making a concerted

effort to include all Parkinson’ s trials in the tool’s database —

with a smart system focused on matching volunteers to trials

and developing relationships that persist beyond an initial

search. An expanded definition of the critical stakeholders is

also key; the tool proactively engages clinical coordinators,

physicians, and caregivers as well as patients themselves.

While it remains early days for this tool, an enthusiastic

response so far reinforces our instinct that a tool leveraging

technology, education and effective communication can

inspire the Parkinson’s population to action in significant

numbers. Within two months of the site’s initial launch, nearly

1,000 potential research volunteers had created profiles;

103 members of trial teams had registered, and personnel

from seven trials had contacted the Foundation after learning

of Fox Trial Finder from patients at their clinics.

“Today, America is waiting expectantly for a new generation of scientific breakthroughs. But we can’t lose sight of a critical element of any success — our own active engagement in the process.”Michael J. Fox

BIOMARKERSThere are no biomarkers for

Parkinson’s disease, meaning

drugmakers don’t know whether the

drugs they are testing actually work.

The Michael J. Fox Foundation-

sponsored Parkinson’s Progression

Markers Initiative exists to identify

biomarkers, putting lines on the

playing field in order to develop new

and better treatments for PD.

+ =

THE FOX EFFECTIdentification of a drug target typically

unfolds in an uncoordinated way as

different labs analyze it from discrete

angles, often at the expense of

opportunities for collaboration. MJFF is

orchestrating efforts to encourage

sharing data and resources early in the

process so that LRRK2 can evolve

toward practical drug therapy faster.

DYSKINESIAA debilitating side effect of current “gold –standard”

treatment for PD, dyskinesia is difficult to study

because it varies in intensity, frequency and duration.

MJFF is pushing dyskinesia treatments toward

patients by working on biomarkers, new drugs and

drug targets and clinical scales simultaneously to

optimize dyskinesia clinical trials. There is great

optimism in the PD scientific community that we will

see successful dyskinesia treatments come to market

in the relatively near future. 1 = 60 months

= 20 months

= 12 months

= 8.6 months

= 6.7 months

3

5

7

9

CLINICAL TRIALSThe serious shortage of participants

in clinical research impedes

therapeutic progress and creates a

tremendous financial burden as trial

timelines expand. The trial in this

example requires 60 patients. The

more patients recruited per month,

the quicker the results and at a

lesser cost.

= 2.4 months25

Total Expenses

$ $ $ $ $ $ $ $

$ $ $ $ $ $ $

$ $ $ $ $ $

$ $ $ $ $

$ $ $ $

The Michael J. Fox Foundation created the Fox Trial Finder tool (www.foxtrialfinder.org) to streamline the flow of volunteers into trials.

By taking a drug already

known to be effective for

another disease and testing it

against Parkinson’s disease,

clinical testing in Parkinson’s

patients can begin much

faster than traditional

therapeutic development

would allow. This means a

treatment can arrive on

pharmacy shelves sooner.

8 m

idye

ar r

epo

rt 2

011

| an

nu

al r

epo

rt 2

010

AcceleratingLRRK2TherapeuticDevelopment

3

NEWTREATMENT

STREAMLINEDTRADITIONAL

OVER 3,000 INDIVIDUALS WITH MUTATIONS IN THE LRRK2 GENE PARTICIPATING IN LRRK2 RESEARCH.

OVER 30 LABS IN THE LRRK2 BIOLOGY CONSORTIUM.

OVER $30 MILLION IN MJFF INVESTMENTS IN LRRK2 THERAPEUTIC DEVELOPMENT TO DATE.

BIOMARKERSThere are no biomarkers for

Parkinson’s disease, meaning

drugmakers don’t know whether the

drugs they are testing actually work.

The Michael J. Fox Foundation-

sponsored Parkinson’s Progression

Markers Initiative exists to identify

biomarkers, putting lines on the

playing field in order to develop new

and better treatments for PD.

+ =

THE FOX EFFECTIdentification of a drug target typically

unfolds in an uncoordinated way as

different labs analyze it from discrete

angles, often at the expense of

opportunities for collaboration. MJFF is

orchestrating efforts to encourage

sharing data and resources early in the

process so that LRRK2 can evolve

toward practical drug therapy faster.

DYSKINESIAA debilitating side effect of current “gold –standard”

treatment for PD, dyskinesia is difficult to study

because it varies in intensity, frequency and duration.

MJFF is pushing dyskinesia treatments toward

patients by working on biomarkers, new drugs and

drug targets and clinical scales simultaneously to

optimize dyskinesia clinical trials. There is great

optimism in the PD scientific community that we will

see successful dyskinesia treatments come to market

in the relatively near future. 1 = 60 months

= 20 months

= 12 months

= 8.6 months

= 6.7 months

3

5

7

9

CLINICAL TRIALSThe serious shortage of participants

in clinical research impedes

therapeutic progress and creates a

tremendous financial burden as trial

timelines expand. The trial in this

example requires 60 patients. The

more patients recruited per month,

the quicker the results and at a

lesser cost.

= 2.4 months25

Total Expenses

$ $ $ $ $ $ $ $

$ $ $ $ $ $ $

$ $ $ $ $ $

$ $ $ $ $

$ $ $ $

The Michael J. Fox Foundation created the Fox Trial Finder tool (www.foxtrialfinder.org) to streamline the flow of volunteers into trials.

By taking a drug already

known to be effective for

another disease and testing it

against Parkinson’s disease,

clinical testing in Parkinson’s

patients can begin much

faster than traditional

therapeutic development

would allow. This means a

treatment can arrive on

pharmacy shelves sooner.

9 sc

ientiFic

pro

gr

ess repo

rt

“MJFF’s LRRK2 strategy allows for a unique approach where academia provides breakthrough science, industry provides capabilities for drug discovery and testing, and MJFF provides necessary disease focus to drive both forward.”Alastair Reith, PhD, Glaxo SmithKline

WithleadingsupportfromtheBrinWojcickiFoundation,MJFFispioneeringanewapproachtostreamlinedrugdevelopmentaroundLRRK2,

themostcommongeneticcontributortoParkinson’sdisease.TheFoundationisfundingaLRRK2BiologyConsortiumofmorethan30investigatorstestingcriticalhypothesesaboutnormalanddiseasedLRRK2;assemblingworldwidecohortsofpeoplewithLRRK2mutationsandtheirfamilymemberswhocanbestudiedtobetterunderstandLRRK2Parkinson’s;leadingdevelopmentanddistributionofcriticalresearchtoolsrequiredtoeffectivelystudyLRRK2;andensuringthatthepharmaceuticalindustry’sexpertiseisleveragedinthepursuitofLRRK2-basedtherapeutics.

KeyMJFFaccomplishmentsinLRRK2:

● Determination that LRRK2 kinase activity is required for

Parkinson’s toxicity (LRRK2 Biology Consortium members

at Johns Hopkins University and University of Alabama at

Birmingham)

● Discovery, development and distribution of a compound

that inhibits LRRK2 kinase activity (LRRK2 Biology Consortium

members at Harvard University and University of Dundee), a

protoype for a possible treatment

● By year-end 2012, development and distribution of an

anticipated 17 LRRK2 pre-clinical models to industry and

academic researchers at reduced costs — and distribution of

another seven (MJFF staff scientists)

● Development and distribution of the field’s now-most-

commonly-used LRRK2 antibodies (critical research tools

to determine where in the brain LRRK2 is functioning and

measure changes in LRRK2 function or expression that may

result from disease) (MJFF staff scientists)

● Establishment of the LRRK2 Industry Advisory Group to

engage with leading pharmaceutical and biotech companies

working in LRRK2 in order to identify and tackle the roadblocks

they face in developing LRRK2-based therapies

NEWTREATMENT

STREAMLINEDTRADITIONAL

OVER 3,000 INDIVIDUALS WITH MUTATIONS IN THE LRRK2 GENE PARTICIPATING IN LRRK2 RESEARCH.

OVER 30 LABS IN THE LRRK2 BIOLOGY CONSORTIUM.

OVER $30 MILLION IN MJFF INVESTMENTS IN LRRK2 THERAPEUTIC DEVELOPMENT TO DATE.

10 m

idye

ar r

epo

rt 2

011

| an

nu

al r

epo

rt 2

010

DrivingNewTreatmentsforDyskinesia

4

DYSKINESIAA debilitating side effect of current “gold –standard”

treatment for PD, dyskinesia is difficult to study

because it varies in intensity, frequency and duration.

MJFF is pushing dyskinesia treatments toward

patients by working on biomarkers, new drugs and

drug targets and clinical scales simultaneously to

optimize dyskinesia clinical trials. There is great

optimism in the PD scientific community that we will

see successful dyskinesia treatments come to market

in the relatively near future.

NEW DRUGS

CLINICALSCALES

BIOMARKERS

DRUG TARGETS

11 sc

ientiFic

pro

gr

ess repo

rt

Similartoourworkinotherhigh-priorityresearchareas,TheMichaelJ.FoxFoundationtakesaportfolioapproachtodrivingnewtreatmentsfordyskinesia.Wehavemade

hearteningprogressidentifyingandtestingpromisingdrugtargetsinthisarea.TodaytheFoundationisworkingwithseveralcompaniespursuingdifferentapproachesincludingaclinicaltrialofmGluR5(AddexPharmaceuticals)andlate-stagepre-clinicalworkonmuopioidreceptors(AdolorCorporation)andnicotine(Targacept,Inc.);we’realsosponsoringaclinicaltrialledbyresearchersatLundUniversityinSwedentargetingspecificserotoninreceptors.Anotheractiveareaofinvestigationfocusesonimprovingthedeliveryoflevodopa,sincecurrentdeliverymethodsarebelievedtogiverisetodyskinesiainthefirstplace.

The Foundation is sponsoring a $1-million clinical study to

validate clinical scales that measure dyskinesia (a must for

designing effective clinical trials of potential new treatments).

And we continue to drive research toward increased

understanding of the cellular mechanisms underlying

dyskinesia to ensure that every promising therapeutic avenue

is identified and pursued.

Toptherapeutictargetsfordyskinesia:

● GlutamatereceptormGluR5.In five years the Foundation’s

de-risking efforts chaperoned mGluR5 from basic discovery to

clinical testing and attracted industry interest in the target. In

August 2010, Addex Pharmaceuticals of Switzerland received

Foundation funding for a Phase 2 clinical trial of an mGluR5-

targeting agent that has shown promise in pre-clinical trials

and a Phase 1 clinical study. Additionally, Novartis is pursuing

clinical testing of mGluR5.

● Muopioidreceptors.Scientific evidence suggests that

increased opioid peptide transmission in a part of the brain

called the basal ganglia might underlie dyskinesia after long-

term levodopa treatment. Agents that reduce this increased

activity might benefit patients experiencing dyskinesia as a

result of taking levodopa for Parkinson’s disease.

● Serotoninreceptors.Researchers at Lund University in

Sweden have been funded by MJFF since 2005 to develop a

dyskinesia treatment targeting the serotonin system, better

known for its role in clinical depression. With Foundation

funding, the researchers are now clinically testing a drug

that has been shown to act on two specific receptors, known

as 5-HT1A and 5-HT1B, located on the serotonin neurons.

Clinicaltrialinfrastructure:

● Validationofclinicalratingscalesfordyskinesia.Significant challenges in measuring dyskinesia and potential

new therapies have created roadblocks to clear-cut trial

results and, therefore, industry investment in dyskinesia.

The establishment of validated scales for dyskinesia clinical

trials would significantly reduce the barrier for biotech and

pharmaceutical companies to invest in this debilitating

aspect of Parkinson’s.

“With support from MJFF since 2005, mGluR5 has moved from basic discovery to clinical testing and attracted investments from two drug companies. There is a lot of excitement about its promise to impact patients’ lives in the near term.” Angela Cenci-Nilsson, MD, PhD, Lund University

BIOMARKERSThere are no biomarkers for

Parkinson’s disease, meaning

drugmakers don’t know whether the

drugs they are testing actually work.

The Michael J. Fox Foundation-

sponsored Parkinson’s Progression

Markers Initiative exists to identify

biomarkers, putting lines on the

playing field in order to develop new

and better treatments for PD.

+ =

THE FOX EFFECTIdentification of a drug target typically

unfolds in an uncoordinated way as

different labs analyze it from discrete

angles, often at the expense of

opportunities for collaboration. MJFF is

orchestrating efforts to encourage

sharing data and resources early in the

process so that LRRK2 can evolve

toward practical drug therapy faster.

DYSKINESIAA debilitating side effect of current “gold –standard”

treatment for PD, dyskinesia is difficult to study

because it varies in intensity, frequency and duration.

MJFF is pushing dyskinesia treatments toward

patients by working on biomarkers, new drugs and

drug targets and clinical scales simultaneously to

optimize dyskinesia clinical trials. There is great

optimism in the PD scientific community that we will

see successful dyskinesia treatments come to market

in the relatively near future. 1 = 60 months

= 20 months

= 12 months

= 8.6 months

= 6.7 months

3

5

7

9

CLINICAL TRIALSThe serious shortage of participants

in clinical research impedes

therapeutic progress and creates a

tremendous financial burden as trial

timelines expand. The trial in this

example requires 60 patients. The

more patients recruited per month,

the quicker the results and at a

lesser cost.

= 2.4 months25

Total Expenses

$ $ $ $ $ $ $ $

$ $ $ $ $ $ $

$ $ $ $ $ $

$ $ $ $ $

$ $ $ $

The Michael J. Fox Foundation created the Fox Trial Finder tool (www.foxtrialfinder.org) to streamline the flow of volunteers into trials.

By taking a drug already

known to be effective for

another disease and testing it

against Parkinson’s disease,

clinical testing in Parkinson’s

patients can begin much

faster than traditional

therapeutic development

would allow. This means a

treatment can arrive on

pharmacy shelves sooner.

12 m

idye

ar r

epo

rt 2

011

| an

nu

al r

epo

rt 2

010

RepositioningExistingDrugs5

FINISH

STARTREPOSITIONING

STARTTRADITIONAL

IT TAKES 10-20 YEARS FOR THE DEVELOPMENT OF A SYMPTOMATIC PARKINSON’S TREATMENT.

REPOSITIONING CAN SHAVEYEARS OFF THIS PROCESS.

BIOMARKERSThere are no biomarkers for

Parkinson’s disease, meaning

drugmakers don’t know whether the

drugs they are testing actually work.

The Michael J. Fox Foundation-

sponsored Parkinson’s Progression

Markers Initiative exists to identify

biomarkers, putting lines on the

playing field in order to develop new

and better treatments for PD.

+ =

THE FOX EFFECTIdentification of a drug target typically

unfolds in an uncoordinated way as

different labs analyze it from discrete

angles, often at the expense of

opportunities for collaboration. MJFF is

orchestrating efforts to encourage

sharing data and resources early in the

process so that LRRK2 can evolve

toward practical drug therapy faster.

DYSKINESIAA debilitating side effect of current “gold –standard”

treatment for PD, dyskinesia is difficult to study

because it varies in intensity, frequency and duration.

MJFF is pushing dyskinesia treatments toward

patients by working on biomarkers, new drugs and

drug targets and clinical scales simultaneously to

optimize dyskinesia clinical trials. There is great

optimism in the PD scientific community that we will

see successful dyskinesia treatments come to market

in the relatively near future. 1 = 60 months

= 20 months

= 12 months

= 8.6 months

= 6.7 months

3

5

7

9

CLINICAL TRIALSThe serious shortage of participants

in clinical research impedes

therapeutic progress and creates a

tremendous financial burden as trial

timelines expand. The trial in this

example requires 60 patients. The

more patients recruited per month,

the quicker the results and at a

lesser cost.

= 2.4 months25

Total Expenses

$ $ $ $ $ $ $ $

$ $ $ $ $ $ $

$ $ $ $ $ $

$ $ $ $ $

$ $ $ $

The Michael J. Fox Foundation created the Fox Trial Finder tool (www.foxtrialfinder.org) to streamline the flow of volunteers into trials.

By taking a drug already

known to be effective for

another disease and testing it

against Parkinson’s disease,

clinical testing in Parkinson’s

patients can begin much

faster than traditional

therapeutic development

would allow. This means a

treatment can arrive on

pharmacy shelves sooner.

13 sc

ientiFic

pro

gr

ess repo

rt

“The concept of repurposing an existing drug is a powerful one. It speaks to our broader mission, which is to push treatments to the clinic and accelerate the whole process.” Todd Sherer, PhD, The Michael J. Fox Foundation

Repositioning(alsoknownasrepurposingorreprofiling)istestingadrugthatisalreadyFDA-approved,orthathasbeenprovensafeinaclinicaltrial,todeterminewhetheritmightworkinotherdiseases.

Byidentifyingtherapiesthatarealreadyclinicallyavailable,TheMichaelJ.FoxFoundationcanpotentiallylessenthetimeandcoststofinddrugsthatcouldhelppeoplelivingwithParkinson’s.

KeyMJFF-ledrepositioningeffortsinParkinson’sdisease:

● With MJFF funding since 2005, the FDA-approved diabetes drug

pioglitazone has now advanced to an NIH-supported Phase 2 clinical

study in Parkinson’s.

● Approved high-blood-pressure drug isradipine is now being tested in

an MJFF-funded Phase 2 clinical study of 100 people with Parkinson’s with

final results expected by year-end 2011.

● In September 2011, the Foundation launched its first repositioning-

specific RFA, funding about $3 million to investigate seven known drugs

that are potentially effective against Parkinson’s.

FINISH

STARTREPOSITIONING

STARTTRADITIONAL

IT TAKES 10-20 YEARS FOR THE DEVELOPMENT OF A SYMPTOMATIC PARKINSON’S TREATMENT.

REPOSITIONING CAN SHAVEYEARS OFF THIS PROCESS.

De-risking Parkinson’s Research for Industry

Repositioning is just one of a broad portfolio of MJFF approaches to lessen the risk for industry players of investment in Parkinson’s disease drug development. As we’ve taken on more projects targeted toward industry, our role in the field has expanded, as has our influence on the agendas of other critical players. In 2010, we formally established an on-staff Research Partnerships team charged with engaging industry leaders across the board, whether in our brainstorming and planning meetings, as funding partners to our significant research initiatives such as PPMI, or in special efforts such as our LRRK2 industry working group.

Today, MJFF has funded over 135 unique projects led by industry, with investments of over $65 million. Our funding to small and mid-sized biotechs has helped move drug targets toward the clinic. Seed grants to large pharma have given PD a seat at the table — and as those grants have become successful the companies themselves have funded their furtherance.

MJFF also has become increasingly involved in developing and distributing tools that make PD drug development more effective and efficient. These include laboratory reagents, pre-clinical models, and biomarkers. And our PD Therapeutics Conference has become the most significant Parkinson’s drug development meeting in the world.

14 m

idye

ar r

epo

rt 2

011

| an

nu

al r

epo

rt 2

010

1. Art Wrubel and Board member David Golub

2. Leadership Council Chairman Scott Schefrin

3. Leadership Council member Sonya Chodry

4. Michael J. Fox and Joan Jett

5. Harper, Jon and Shanna Brooks, Tracy Pollan and Michael J. Fox

6. Leadership Council member Amar Kuchinad and Team Fox mentor Susan Bilotta

7. Lauryn Hill performs on the Funny Thing stage

8. Board member Holly Andersen, MD, and Alison Forns

9. Team Fox members Marian and Janet Clough

10. Leadership Council member Richard Fitzgerald

11. Board member John Griffin and Amy Griffin

12. Board member Karen Finerman, Jeff Glickman, Board member Al Glickman and Co-Founder & Executive Vice Chairman Debi Brooks

13. Dick Nicely and Board Vice Chairman Woody Shackleton

14. Michael J. Fox with the steering committee of the Parkinson’s Progression Markers Initiative (PPMI)

2010inPhotos

1. 2.

3. 4.

5.

All captions listed left to right

15 year

in pH

oto

gr

apHs

14.13.

10. 11. 12.

9.

7.6. 8.

16 m

idye

ar r

epo

rt 2

011

| an

nu

al r

epo

rt 2

010

2010DonorListing

In2010,withthehelpofmorethan47,000individuals,corporationsandfoundations,TheMichaelJ.FoxFoundationfundednearly$50millioninresearch.Thegenerosityrepresentedinthesepagesallowsustocontinuepursuingbreakthroughsthatwilltransformmillionsoflives.

ThisreportlistsfriendswhohonoredtheFoundationwithsignificantcontributionsin2010.Alsolistedarethosewhosememoryandspiritinspiredtributegifts.TheirnamesareacontinuingreminderoftheurgencyofourmissiontomakeParkinson’sdiseaseathingofthepast.

2010IndustryPartnerships PPMIAbbott LaboratoriesGE Healthcare* Genentech, Inc.Pfizer, Inc. F. Hoffmann-La Roche Ltd.

ResearchPartnershipsElan Pharmaceuticals, Inc.

SponsorshipsBoehringer IngelheimPharmaceuticals, Inc.Elan Pharmaceuticals, Inc. EMD Serono, Inc. Park IP TranslationsTeva Neuroscience, Inc.

Wearegratefultothesepharmaceuticalandbiotechcompaniesfortheirsignificantcommitmenttohelpusacceleratelife-transformingtreatmentsforParkinson’sdisease.

$25,000,000ormore The Brin Wojcicki Foundation

$10,000,000ormore Chris Sullivan*

$2,500,000ormoreJudith and George Prescott and Family*Mrs. Edmond J. Safra

$1,000,000ormoreAnne and Burt Kaplan*The Edmond J. Safra FoundationShackleton Family*

$500,000ormoreBenaroya FoundationGreat Investors’ Best Ideas Foundation/ Michele and Shad RoweShannon and Mark L. Hart III Estate of Lucile Traeger

$250,000ormoreCheryl and David EinhornJudy and Albert GlickmanRachel and Amar KuchinadEstate of Dorothy LesherMarilyn MuirJulie and Doug OstroverKim and Terry PegulaCarolyn and Curtis SchenkerKaren Pritzker and Michael Vlock Jessica and Sonny Whelen

We are also grateful to the following partners who signed on to support PPMI in 2011: Biogen Idec, Covance,* GlaxoSmithKline and Merck & Co.

*In-kind support

* recognizes multi-year commitment

17 d

on

or

listing

continued on page 18

$100,000 or more

Anonymous (2)

Holly Andersen, MD, and Douglas Hirsch

BTIG, LLC

Cantor Fitzgerald

Claire and Jason Capello

The James E. Cayne and Patricia D. Cayne Charitable Trust

Joyce and Barry Cohen

Simon & Eve Colin Foundation*

Consolidated Anti-Aging Foundation

Tracy Pollan and Michael J. Fox

The Sol and Lillian Goldman Family

Karen Finerman and Lawrence Golub

Lazard Capital Markets

Carolyne and Edwin Levy

The Lineage Fund

Jennifer and Marc Lipschultz

Parkinson’s Unity Walk

Ronald O. Perelman

The Pumpkin Foundation/ Joe and Carol Reich

Estate of Jack Roth

Martin B. Unger Estate

$50,000 or more

Anonymous (2)

Estate of Tom Adler

The Bachmann-Strauss Dystonia & Parkinson Foundation, Inc.

Barbara and Julian Cherubini

Sonya and Dev Chodry

The Community Foundation for the National Capital Region

Lauren and Lee Fixel

Linda and Ron Galowich

Carl Gardecki Trust

Goldman, Sachs & Co.

Lisa Piazza and David Golub

Amy and John Griffin Foundation

Allison and Casey Maguire

The Miller Family Foundation

Catherine and John T. Morse

New 28th Floor Productions, Inc.

Pershing Square Capital Management, LP

Prince Charitable Trusts

The San Diego Foundation

Anne-Cecilie Engell Speyer and Rob Speyer

$25,000 or more

Anonymous

Lisette Ackerberg

Eva Andersson-Dubin, MD, and Glenn Dubin

Bank of America Merrill Lynch

Bloomberg

Shanna and Jon Brooks

William and Mafe Bunga Revocable Trust

Ellen Hooker and Joseph Cassano

Castlewood Apparel Corp.

Chatham Asset Management LLC

Citi Business Services

Steven A. and Alexandra M. Cohen Foundation

Ellen and Casey Cogut

Katie Couric

DEARS Foundation, Inc.

George S. DeHesus, Sr. Trust

The Robert & Connie Delaney Foundation

Deloitte Services LP

Donny Deutsch

Deutsch Inc.

Deutsche Bank Securities, Inc.

The Ettleman Family Fund

Julie and Jonas Fajgenbaum

French American Charitable Trust/Caroleen Feeney

Richard H. Fitzgerald

Danielle and David Ganek

Jay Goldman

Meg and Bennett Goodman

Michelle and Cyrus Hadidi

Susan and Kim Henry

Marjorie and Robert Hirschhorn

Hollywood Boulevard Cinema LLC

Sonia and Paul T. Jones

The Kalikow & Platt Families

Marilyn and Jeffrey Katzenberg

KPMG, LLP

Marie Josee & Henry R. Kravis Foundation

Margaret and Daniel Loeb/ The Third Point Foundation

Robert G. Lusk Trust

Joella and John Lykouretzos

M&T Trust

Sandra Milken

Mirken Foundation

The Garrett and Mary Moran Family Foundation

Morgan Management – Robert Morgan, Robert Moser, Chase Chavin and their families

Laurie and Asher Platt

Julie Turaj and Robert Pohly

Poses Family Foundation

Profiles in History

Public Strategies, Inc.

Rawley Foundation

Aliza and Joshua Rosman

Carolyn and Marc Rowan

Pam and Jon Scarborough

Elizabeth and Scott Schefrin

The Edward I. Seagraves Fund

Michele and Kenneth Seim

Jill and Bill Shepherd

Elsa and Stanley Sidel

Signature Bank

Simpson Thacher & Bartlett

Iris Smith

Sheila and Tripp Smith

Winthrop H. Smith Family Foundation

Morgan Stanley

Debbie and Henry Sutton

Mildred E. Swanson Foundation

Maida and Ralph W. Tryon

Vinson & Elkins LLP

Stacey and Reid Walker

Amy and Fred Weiss

Bill and Sara Wilkins

Lise and Jeffrey Wilks

Jane and Neil Yaris

Lila Zakon Trust under the Will of Jessie S. Kravitz

$10,000 or more

Anonymous (5)

Air Dimension Inc

Allen & Company

The Ammon Foundation

Anchin, Block & Anchin LLP

Ark Partners

Chip R. Ashby

B7 Ranch Operating Account

Kyle Bass

Sylvia Marie Becherer Revocable Living Trust

Estate of Helen Bennett

Andrea Billhardt

Charles Thomas Bobrink Trust

Nicholas Botta

Debi and Jeff Brooks

W.L. Lyons Brown Foundation

Linda S. Byars

Patrice M. Campbell

$100,000 or more $25,000 or more Canada’s Olympic Broadcast Media Consortium

Capital One Bank

Minnie W. Heinemann and Deborah O. Carder Co. TTEES

Susan and Nicholas Carter

Carolyn and Stephen Chase

The Louis and Virginia Clemente Foundation

Coach Foundation Inc

Colella Family

Toby Cooper

Camille and Michael Costa

The Anthony M. Cotoia Foundation, LLC

Basil J. Coughlan II

Estate of Josephine M. Cretnik

Rachael Ray and John Cusimano

Norah and John Daly

The Dancing Skies Foundation

Dancing Tides Foundation, Inc.

The Joshua P. and Elizabeth D. Darden Foundation

Jill and Jeffrey Degen

Delta Marketing International LLC

Lynn Diamond

Josefina Diez

Mr. and Mrs. Edward J. Dobbs

Corinne L. Dodero Foundation for the Arts & Sciences

EarthBound

Caryn and Craig Effron

Valerie Feigen and Steven Eisman

Thomas and Jeanne Elmezzi Private Foundation

The Emerson Hermetic Motor Division

The Lois and Richard England Family Foundation

The Fishman Family Fund/Randy and Jay Fishman

Cherie and James Flores

Dr. Marsha Heinke and Dr. Lawrence Forthofer

Grace M. Fowler

Rochelle and David Fredston

Dahna Brecker-Freidus and Harris Freidus

Julianne Moore and Bart Freundlich

The Garcia Family

Christen C. & Ben H. Garrett Family Foundation

Larry Gemoets

Adele and Howard Gewirtz

Diana Meehan and Gary David Goldberg

Stephanie and Robert Goldstein

Leslie Finerman and Sean Goodrich

Rachel and Warren Goodrich

The Grateful Foundation, Inc.

Ellyn and Michael Greenspan

Lois and Alvin Gross

The Hajim Family Foundation

Michael J. Harkins

Kathy Harris

Armin & Esther Hirsch Foundation

Ashley and Rusty Holzer

Debbie and David Horn

The Howard Family Charitable Fund/Carla and Scott Howard

Paul Huchro

Imperial Capital, LLC

Ann and Skip Irving/Health Advances, LLC

The Rona Jaffe Foundation

Jewish Communal Fund

Jewish Community Foundation

Eleanor Francis Nelson Jordan

Francesca Judge

Eric and Michael Karsch

Anne and Jeff Keefer

Mary and Richard Ketchum

The Keyser Family

Kramer Levin Naftalis & Frankel LLP

Sallie L. Krawcheck

Julie and Jim Kress/The George Kress Foundation Inc

Jenny Hewlett and Adam J. Kutas

The Leonard & Evelyn Lauder Foundation

Lenado Capital Advisors LLC

Wendy and Douglas Liebhafsky

The Lobster House

Debbie L. Logan

Tami and Fredric Mack

The Tim and Janet Maher Charitable Gift Fund

Make It Possible Foundation, Inc.

Mary and Robert Mandell

Nancy and Howard Marks

Kathleen Kennedy and Frank Marshall

Trish McEvoy Beauty

Meltzer, Lippe, Goldstein & Breitstone, LLP

Norman A. Merollis

The Michelson Foundation

$50,000 or more

$10,000 or more

* recognizes multi-year commitment

18 m

idye

ar r

epo

rt 2

011

| an

nu

al r

epo

rt 2

010

continued on page 20

continued from page 17

Buchalter Family Trust

Susan and Sy Budman

Karen and Todd Builione

Emily W. Burns

Ms. Valerie A. DiFebo and Mr. James D. Byrne

P.A. Calder

The Carmen Foundation

Stephanie and Wayne Caron

Jock Casasus

Cattoor Family

Linda and Bernard Chalfin

J. Dawn and Mark Christman

Stephanie and Chase Coleman

Wendy and Victor Coleman

Robert A. Coldwell Revocable Trust

Judy E. Corrigan

Cures and Hope USA, Inc.

Edward H. and Dawn L. D’Alelio

Gavin De Becker

Joseph Deal

Mark Dickstein

Don P. Dizon

Bosko Djordjevic

Suzanne and Jacob Doft

Richard Dorfman

Kenneth Douglas Foundation

Stephen M. Dowicz

Hillel and Meira Drazen

Ralph Eads/Jeffries & Company, Inc.

Cheryl and Blair Effron

James C. Ellis

Eugene Marathon

Quinn and Bryan Ezralow

Firman Fund

Nedra R. Fischer

Christine and Todd Fisher

Randi and Mark Fisher

Marcia and Mike Flowers

Fowey Light Fund, Inc.

Mr. and Mrs. Alan Fragan

Lynn and Joel Frank

Farrell Fritz, PC

Chris Furie

Lori and Simon Furie

Jeff Galowich Family

Ellen Gaslow

The Gale Family Foundation, Inc.

Amy and Jonathan Gallen

Pat and Charles Genuardi

Nancy and Jonathan Glaser

Deborah and Brian Gottlieb

The Tom and Bonnie Grace Family Foundation

Scott Sonkin and Friends

Sound Diagnostics

South Palm Beach Chapter NPF

Henry Spector

Corey Hajim and Jim Sperber

Alexandra Wentworth and George Stephanopoulos

Lisa and Scott Stuart

Stupell Foundation, Inc.

Ram Sundaram

Ariel B. Taitz

Tamkin Foundation, Inc.

Levino Tittaferrante

Toronto General and Western Hospital Foundation

Marie J. Toulantis

Karin and Kenneth Travis

The John D. Turkel Revocable Trust

Mr. and Mrs. Charles Tyler

Tyler Family Charitable Gift Fund

Susan and Donald Ullmann

United Talent Agency

Vanguard Charitable Endowment Program

The Walsh Family

Diana Wasserman-Rubin and Richard Rubin

Wells Fargo Insurance Services of New York, Inc.

JR & MJ Wilson Foundation

Joan B. Wilton

Winthrop Lodge of Elks 1078

Daniel Wolf

Barbara and Stanley Zax

$5,000 or more

Anonymous (6)

AHAB Capital Management, LP

AK Steel Foundation

Carrie and Robert Andalman

Estate of Sam M. Anderson

Karen and Greg Arrese

Assured Environments

Babior Foundation

Anthony Baer

Lino J. Bailo Trust

Barclays Capital

Michael Bay

Ms. Brooke Benaroya

Robin and Ed Berman

Dan & Merrie Boone Foundation

Bridgeway Federal Credit Union

Eugenia Brin

Nina and Joe Brown Family Philanthropic Fund

Leo Miller Family Foundation

Alice and Rodman W. Moorhead III

Estate of Martin Nash

The Natter Family Foundation

Network for Good

Nancy and Bruce Newberg

Kim and Dick Nicely

Dick D. Nopar

Mr. and Mrs. Scott Nuttall/Nuttall Charitable Fund

Marvin W. Nyswonger

Oak Creek Foundation

Jane and Daniel Och

Jennifer and Sean O’Neal

Kimberly Williams-Paisley and Brad Paisley

Park Avenue Charitable Fund

Jean Patton 2005 Revocable Trust

Pepsi Bottling Ventures LLC

The Geraldine and Eugene Pergament Education Fund

Philpott Bills Stoll & Meeks, LLP

Liz and Eric Pitcher

Lea and Barry Porter Fund

Mrs. Jeanne F. Coleman and Mr. Lawrence F. Portnoy

Jill and Mark Rachesky

Paul Raether/The Raether 1985 Charitable Trust

Bobbi and George Rainwater

Patricia Jehle and James Reidy

RLG Foundation, Inc.

Mr. and Mrs. Clifton S. Robbins/The Robbins Family Foundation

Edward Robinson

Larry Roi

David L. Rosen Revocable Trust

Allen Rosenberg

Denise and Scot Rosenblum

Francesco Scattone

Melissa Benzuly and Jonathan Schaffzin

Schwab Charitable Fund

William and Jacqueline Shaw Family Foundation, Inc.

Showtime Networks, Incorporated

The Melvin and Bren Simon Charitable Fund

Harry S. Sloane Foundation

Jean S. Smith Revocable Trust

Michelle and Chuck Smith

The Smolin Family Trust

Solvay Finance (America) Inc.

Carol Case-Lieberman and Ira Lieberman

The Meltzer Lippe Foundation

Holly and Jonathan Lipton

Mark Litofsky

The Litwin Foundaiton, Inc.

Deborah and Jim Long

Amalia and Peter Lucas

Stefanie Meisel and Scott Macklin

Magna Carta Foundation

Ellyn and Michael Maguire

The V & L Marx Foundation

Diane and Richard Mason

Joan and Robert Matloff

Priscilla and George Matouk

Maverick Capital Foundation

The Noreene Storrie and Wesley G. McCain Family Fund

Howard McClure

Cynthia and Michael McConnell

Helen M. McGinn

McKeon Products

McKesson

Jodi and Kenneth Meister

Michael Meldman

Sue and Fred Menowitz

Merrick Bank Corporation

Estate of Robert M. Miller

Mr. and Mrs. Michael G. Miller

Estate of May Moore

Estate of Josephine Laura Morrison

George M. Murray III Revocable Trust

Muskin Family Foundation

Mary and Warren Myer

Tracy and Larry Nagler

Robert D. Nankervis

National Philanthropic Trust

Mary and Alexander Navab

Gabe Nechamkin

Newmark & Company Real Estate, Inc.

Joyce and William Niles

Earline Arnold and Deryck Nuckton

Nomura Securities International, Inc.

Peter O’Maley

Oppenheimer Funds, Inc.

Parkinson Association of Northern California

Parkinson Association of the Rockies

Chitiz Pathak, LLP

Denise and Donald Paulus

The George & Reva Graziadio Foundation

Vicki and Michael Gross

Jennifer and Bud Greunberg

Abby and Eugene Gurkoff

Marni and Bruce Gutkin

Gayle D. Halpin

Deborah and Jeffrey Hamer

Susan and Richard Hare Family Foundation

Gates H. Hawn

Susan and Roger Hertog

The Sandy Hill Foundation

Wandy Yeap Hoh and William Hoh

David Hollender/Betty Jane Hollender Foundation

Rachel Kohler and Mark Holamazian

James Holmes

Katie and Aaron Hood

Judith and Michael Hooffstetter

Hurlbert Family Foundation

Johannes P. Huth

IBM Corporation

ITAGroup Foundation

Dr. and Mrs. Joseph Jankovic

The Robert Wood Johnson Foundation

Mr. and Mrs. David O. Jones

Josflo Corp.

Drs. Julie and Scott Kalniz

Amy and Dan Kamensky

Warren B. Kanders Foundation/Allison and Warren Kanders

The Jerry Katz Trust

Carol and Jerry Katzman

Fritz and Adelaide Kauffman Foundation

Joy and Eric Kaye

Steven and Debra Kilian

The Kitay Family Foundation

Paul Klinger

Marjorie and Russell Knauer

Knight Trading Group, Inc.

John & Evelyn Kossak Foundation, Inc.

Kris Kotars

Mr. and Mrs. Bruce Kovner

Bernard Kravitz

Christina and Barry Kringstein

David Krinsky Charitable Fund

Lagunatic Music/ Filmworks Inc

Christa Miller and William Lawrence

Dr. and Mrs. Lawrence E. Lee

$10,000 or more

$5,000 or more

19 d

on

or

listing

The Challenge comes at an opportune moment.

As we look ahead toward the next phase of

our work, several conclusions emerge. First and

foremost, our model is working. Due in no small

part to over $260 million in MJFF investments

since 2000, the stage of Parkinson’s drug

development as a whole is moving forward.

We have funded work on over 100 therapeutic

targets, and, with our backing, several have taken

significant steps toward clinical testing and

practical patient relevance.

This is exciting. Yet it also poses new challenges

for our problem-solving. As resource-intensive

as pre-clinical research is, the clinical projects

we see on the horizon come with exponentially

steeper price tags. New tools and strategies

are required to rally the patient community to

volunteer to take part in studies that urgently

need them. And we must continue to vet new

and existing potential therapies at every stage of

development to identify the most promising and

push them closer to pharmacy shelves.

If we can raise the $50 million we need, the Brin

Wojcicki Challenge will expand our capacity to

streamline and fund targeted research toward

Parkinson’s breakthroughs. It will allow us to bring

our successful out-of-the-box strategies into critical

areas that remain underfunded. It will aid our

continuing efforts to drive pre-clinical research,

lead groundbreaking public-private partnerships,

and attract broad expertise to address the unmet

medical needs of Parkinson’s patients.

TheMichaelJ.FoxFoundationhasbeenchallengedbylongtimeFoundationfriendsSergeyBrin,co-founderofGoogle,andhiswife,AnneWojcicki,co-founderofpersonalgeneticscompany23andMe.Ifwecanraise$50millionin

capacity-buildingfundsbyyear-end2012,SergeyandAnnewillmatchitdollar-for-dollar.

Lifetime Leadership Support

Over$80,000,000The Brin Wojcicki FoundationOver$10,000,000The Edmond J. Safra Foundation/ Mrs. Edmond J. SafraChris SullivanOver$5,000,000Benaroya FoundationTracy Pollan and Michael J. FoxKinetics Foundation

Over$2,000,000Steven A. and Alexandra M. Cohen FoundationCheryl and David EinhornElan Pharmaceuticals, Inc.EMD Serono, Inc.Judy and Albert GlickmanGreat Investors’ Best Ideas Foundation/ Michele and Shad RoweAmy and John GriffinAnne and Burt KaplanThe Pioneer Fund

MJFF honors these contributors whose consistent support since our inception enables high-impact research initiatives to bring a cure for Parkinson’s closer.

Judith and George Prescott and FamilyCarolyn and Curtis SchenkerBernard and Anne SpitzerThe Dotha S. Welbourn Charities Trust

As of December 31, 2010

20 m

idye

ar r

epo

rt 2

011

| an

nu

al r

epo

rt 2

010

continued from page 18

Peerless Beauty & Barber Supply

Barbara H. Pekow

Sandra and Norman Pessin

Kawai Lani and Alexander G. Piper

Pirates in Paradise Inc.

The Donald Lee Pluger Living Trust

Corky and Stephen Pollan

Lea and Barry Porter Fund

Marc Porter

Judith Spencer Price

The William L. Price Charitable Foundation

Pugliese Family Charitable Fund

David O. Radloff

Bradley L. Radoff

Larry F. Randall

Linda and Richard Reiss

Resslser/Gertz Family Foundation

Stuart Robbins

George R. Roberts

Sharon and Scott Robinson

Ginger and William Rosenbaum

Marcia and James Rosenheim

Georgina and Alan Rothenberg

Marie and Stephen Rozan

Allison and Neil Rubler

Arthur N. Rupe Foundation

The Shack Sackler Family

Gregory Sain

James and Janet Sammer

Mara and Ricky Sandler

Schaner & Lubitz, PLLC

Lisa Rotmil and Alex Schmelzer

Jennifer M. Schneck

Meryl and Jeff Schwartz

Virginia and David Schwartz

John J. Schwenkler

Anshu and Vinit Sethi

Nancy A. Sharko

Sigma-Aldrich

Fiiona and Steven Silver

Simbat Foundation

Dana and Edward Slatkin

Mary and Richard Slaughter

Phyllis and Rick Slocum

Dione and Joseph Smith

Lauren and Kevin Smith

Maureen and Glen Smith

Sony Corporation of America

Tina and Mark Stacy

Star Industrial Service Co., Inc.

Marianne and Roger Staubach

Lonna Williams and Michael Stolper

Dana and Andy Stone

Carol and Jim Storm

Jennifer and John Streit

Esperanza C. Stuart

Frank L. Sustersic

Samer Takriti

Kim and Eric Tannenbaum

Tecca Foundation

Kent M. Thornbrugh

Tiger Global Management LLC

Joanne and Alfred Tobin

The Toole Charitable Foundation

Brian Tudda

Ullmann Family Foundation

Unifi, Inc.

I. Waldbaum Family Foundation

David Wah

Perrie Weiner

The Harold Wetterberg Foundation

Carole and Rick Wiederhorn

Teresa L. Wilde

Mr. and Mrs. Sears Winslow

Mary A. Wintzer

Bruce Wisnicki

Jan and Eddie Woods

Gabriel A. Zamora

May Zawaideh

Ruth Zinar

Estate of Melvin S. Zuckerman

$2,500 or more

Anonymous (2)

Jorge and Monica Acquaviva

Kenneth Aidekman Family Foundation

Mary and Edward Allen

Jack and Sylvia Altman Foundation

Bainbridge Partners, LLC

Thelma and Ray Balbes

Ball Corporation

Bank of America Charitable Fund

The Baxter International Foundation

Barbara S. Baxter

The Edward F. & Barbara A. Bell Family Foundation

Bonni and Alan Berger

Carolyn and Don Berger

Ellen Blackstone

Charles J. and Brenda Block Family Philanthropic Fund

Mark J. Boujoukos

Marcia and Dennis Brager

The Eli and Edythe L. Broad Foundation

Kelly and Andrew Brooks

Nicole and Brad Brooks

Lynn Brown

The Elsie A. Brown Fund, Inc.

Keith N. Browning Family Foundation

Phyllis Richman and Bob Burton

Calvin and Kelly Carter F amily Foundation

Jeremy Carton

Chaflin Reality LLC

Paul Wai Bun Chan

Rita and Herbert Chestler

Daisy Prince and Hugh Chisholm

Joel Citron

Stacy and Richard Clark

Mr. and Mrs. S. Michael Cohen

Kevin and GP Condon

The Jim and Barbara Conen Charitable Fund

Carier and Michael Connell

Bruce Connor

Todd J. Copeland

Beth and Kenneth Corbin

Corn Products International

Joan and Roger Cramer

Credit Suisse Securities (USA) LLC

Crowdrise

Billy and Renee Curtis

The Dance Theatre Company

Brenda Daniel

Nancy and Russell Davidson

Nina and Mitch Davidson

Kimberly Ann Davis

Winifred Quinn DeJesus

Shohali and Gautam Dhingra

Harriet Ford Dickenson Foundation

The Rudy & Jane Dinunzio Irrevocable Trust

DLA Piper US LLP

Mary E. Dooner Foundation, Inc.

Jennifer Dunlap-Markson

Marsha and Anthony Durniak

Drs. Jane and David Eger

Marty and Dale Ehrenreich

Mr. and Mrs. Lewis Eisenberg

Bruce W. Elder

Jonathan Elias

Elsevier Inc.

Lisa and Christopher Engel

Raymond and Jane Epstein

Mr. and Mrs. Ben Ettleman

Nell Everman

Marlou Everson

Linda and Terry Eward

Scott Fahey

Mary and Bruce Feay

Amanda and Michael Feinsod

Debbie and Richard Fife

Fifth Street Capital

Michele and Drew Figdor

Fondue 26, LLC

Fox Vance Family Foundation

Mr. and Mrs. Alan Fragen

Mark Frey

Judy Hecker Furman and Matthew Furman

Beth and David Genuardi

Laurel C. Gerhat

Robert Gersh

The Gerson Family

Gerson & Gerson, Inc.

Myrna and Mike Ginsberg

The Irwin N. Gold Family Foundation

Laurie and Jeffrey Goldberger

Maya D. Goldschmidt

Mitchell and Lenore Goldstein

The Gould-Shenfeld Family Foundation

The Greater Cincinnati Foundation

Leslie Greene and Bob Greenberg

David Groom

Amy L. Gross

Vicki and Michael Gross

Stephen Haberkorn

Ginger and Larry Hahn

Nick Halikis

Sean Handler

Judy and Joseph Harding

Katie Hartgerink

Brenda Harter

Hugh Harvey

Robin Preble and Daniel Hedlund

Sheila and Jonathan Herr

Bill Herzig

Fred and Jane Herzner of The Greater Cincinnati Foundation

Hilcorp Energy Company

Karen and Craig Hill

James D. Hoffman

Teresa Holler

Benjamin and Jessica Hoyer

Illinois Tool Works Foundation

Ingram Family Foundation

Innovative Software Solutions, Inc.

Valerie Fronstin-Akins and Robert Iverson

Jamakepe Foundation

Sheryl and Tony Jedlinski

Sheila Jefferson

The Joelson Foundation

Barbara and Mike Johnson

Harry Johnson

Patti and Lee Johnson

Pamela and David Johnston

Juvenile Diabetes Research Foundation International

Laura and Michael Kahn

Peter S. Kalikow

Marcy Kaplan-Gold

Esther and Harold Kassab

The Katz Foundation

Michael Kelly

Michael H. Kelson

Harris and Eliza Kempner Fund

Katie and Matt Kenseth

Patricia Stonesifer and Michael Kinsley

Kit Kat Club

Bonnie and Bradford Klein

Jerry Klein

Yvette and Roger Kotch

David A. Kovner

Kucera Family Foundation

Ana and Philippe Laffont

Sara and Swayne Latham

Mary M. Laughney

Laurel Conqueror Association Inc Smoller Scholarship Fund

Phillip E. Ledin

Katherine Lehman

Lehman Family Charitable Giving Fund

The Leibowitz and Greenway Family Charitable Foundation

Jonathan Lender

Justin D. Lepone

Wallace R. and Bernice E. Leslie Memorial Fund

Gloria Levine & Harvey Levine Charitable Foundation

Edward and Jami Levy Foundation

Steven Levy

Jeff Liebenstein

John Magnuson

Joel Mandel

Michael Mandel

Laura and Will Manuel

Markit North America Inc.

$5,000 or more

$2,500 or more

21 d

on

or

listing The MJFF Legacy Circle

If you have made estate plans that include MJFF and would like to be listed as a member of The Legacy Circle, please call Sheila Kelly at (212) 509-0995, ext. 214.

continued on page 22

$2,500 or more

Soania and Arun Mathur

John L. McHigh Foundation, Inc.

Dennis M. McIntosh

Medicus Foundation

Sylvie and Lee Millstein

Phyllis W. Miller

Daniel and Sandra Moore

Morgan Stanley

Edith and Walter Mossberg

Lee Munder Capital Group, LLC

Gary and Kary Myers Fund

The New York Community Trust

Chris Nichol

Northrop Grumman Corporation

Northwest Georgia Parkinson Disease Association

Mary Anne and Donald K. O’Brien

Marlene Osthoff

Jeffrey Ostrove, PhD/ Ceregene

Gerald Ouderkirk

The Pacer Foundation

Timothy Paisley

Katharine and Bret Parker

Parkinson’s Celebrating Life

Parry Family Trust

Amy and Joseph Perella

George Perez

Sara Jamison and David Phillips

Sylvia L. Polen

Judith Belzer and Michael K. Pollan

Premier Natural Resources

Marla and Dean Provost

R.S. Quality Products, Inc.

William Ratajack

Ray Laethem Buick GMC

Mary and Christopher Reaske

Katherine and Michael Renoff

The Philip W. Riskin Charitable Foundation

Michael R. Romanowski

Allen J. Ross

Eric Rothfeld

Shani and Douglas Rothschild

Thomas J. Sabourin

Carol and Eddie Sacks

Abby and Steve Sakwa

Sanofi-Aventis

Carl Schecter

Henry Schein, Inc.

Kim and Martin Scheinberg

The Lewis Schott Foundation

The Seiger Family Foundation

Dylan Sellers

Mr. and Mrs. Mark Shapiro

Margaret A. Sheehan

Linda and Bob Sims

Daniel Small

Amy and Howard Smith

Austin Smith

Hugh C. Smith

Jude and Joseph Smith

Sydell and Ira N. Smith

Soboa Band of Luiseno Indians

Jeff Soffer

Mary Ann and Michael St. Peter

Dan Stark

Campbell Steketee

Jackie and Craig Steel

Spencer Stuart

Springbox

Sugar and Spice Bake Shop

Sundance Running Club

Gary Suttle

Suwyn Family Foundation

Dixie Swanson

Ariel B. Taitz

The Elizabeth and Leonard Tannenbaum Charitable Fund

Heather Taylor

Tekniverse, Inc.

Marilyn G. Thompson

Titan Outdoor LLC

Tower Hill School

Gail and Richard Ullman

Brian S. Verona

The Peggy & Ellis Wachs Family Foundation

Stephanie Wagner

Dr. and Mrs. John R. Walch

Phyllis J. Warrick

Anne and William Washychyn

Andy W. Weatherwax

Lindsay and William Webster

Sheila and Edward Weidenfeld

Julie and Peter Weil

Debby and Peter Weinberg

Norma and Ed Weinman

Andi and Bob Weiss

Melvyn I. Weiss

Linda and Patrick Welch

Wesley Capital Management LLC

Daniel and Kristin Wilkins

Lynn Wilmas

Diane Wilsey

Florence and Robert Woolery

Gerald Wright

Wanda and Charles Young

Derek Zaba

Mr. and Mrs. Wayne R. Zdenek

Marek Zejda

The Zemeckis Charitable Foundation

Michele and Adam Zipper

1,000 or moreAnonymous (4)

The 100 Times Foundation Corporation

A & E Kaplan Foundation

Nancy and Colman Abbe

The Gerald Abell Foundation

Iris Aberbach

Kamal Aboul-Hosn

Kathleen McGrath and J.J. Abrams

Edith Abramson

Denise and Herb Abrash

Cesar Acosta

Hope Adelstein

Advanced Implant Dentistry & Oral Restoration

Aggressive Energy & Mechanical Group

David Agraz

$1,000 or more

Anonymous (9)Sylvia Marie Becherer Revocable Living TrustRichard BelmanLori BoettoVirginia BrooksJock CasasusBeverly and Calvin ChadwickBarbara and Arnold CohenFrederick C. Colton

Frances Reser Coody in memory of John Lester CoodyLarry and Anne DavisEstate of Sam M. AndersonEstate of Lisa Susan Baricelli-KureenEstate of Helen BennettEstate of Ruth CarterEstate of Alma ChitwoodEstate of Diane Mae ClarkEstate of Josephine M. CretnikEstate of Henry CzerwiecEstate of Beryll DemingEstate of Marjory S. FellmanEstate of Rafael Joseph GonzalezEstate of Iva Pauline HancockEstate of Pollyanna HerrellEstate of Helen HoskinEstate of John Christopher KimmeyEstate of Dolores E. Kossak

The Legacy Circle honors friends who support the Foundation’s work through bequests or other planned gifts. While MJFF’s mission has always been to put itself out of business by curing PD, planned gifts provide a major, long-term funding source that we can both plan around and leverage immediately to accelerate high-impact research.

Estate of Louis KriegerEstate of Raymond H. LakeEstate of Byron MavrelisEstate of May MooreEstate of Sidney Kanz MorganEstate of Martin NashEstate of Melvin RauchEstate of Marjorie E. RichardsEstate of Eileen R. SalterEstate of Lucile TraegerJanet and Robert B. EttlemanJeff EvansBarbara FolenderDonald and Martha B. Geibel TrustMargaret C. Glosser Irrevocable TrustPeter GonsalvesJuan GriegoAndrew S. GroveThomas K. & Yvonne G. Hanes Charitable Remainder Trust

Lee HermanThe Hoover Family Charitable Remainder TrustMary HopkinsJudith and Charles HussEleanor Francis Nelson JordanThe Jerry Katz TrustRev. Dolores K. KimseyRose KriegerDeborah and Jim LongSally and Andrew LorenzThe Edmund Ernst McClure TrustJanet McCroryKaren A. OliverDon and Ruth Palmer EstateEstate of Jean PattonJohn Richard RandallEstelle RandolphGale ReevesElfrieda Remlinger Revocable Living Trust

Judith Snow RiedelThomas SabourinManuel Schneider Living TrustDr. Jules I. SchwartzHenry SpectorDorothy StraussThe Sutherland FamilySophia Tomich Living TrustThe John D. Turkel Revocable TrustAlessio and Flora VenturaDr. Brent and Terry WeinbergerElizabeth H. WeinraubDotha S. Welbourn Charities TrustCharles C. White Revocable TrustKathryn P. WrightYacuone Living TrustLila Zakon Trust under the Will of Jessie S. Kravitz

22 m

idye

ar r

epo

rt 2

011

| an

nu

al r

epo

rt 2

010

Frank Aiello

Brenda and Robert Aiken

Roger E. Ailes

Mr. and Mrs. Safdar Akbar

Barbara and John Alden

Steven A. Alexander

Michelle B. Alifanz Carson

All Area Services

George V. Allen

Julie and David Allen

Allon Therapeutics Inc.

Aloutte Old Orchard Beach Oceanfront Resort Incorporated

Margaret Alsup Trust

William E. Alt Charitable Fund

The Alter Group, LTD

American Agricultural Insurance Company

Joe Andronaco

Richard P. Anthony

Antonio’s Coiffures LTD

Dane Arden

Meg and Jeff Arnold

Merieluise and Ed Artzt

The Stanley and Blanche Ash Foundation

Asheville Cotton Company

Christine C. Atkinson

Austin Community Foundation

Automatic Data Processing Inc.

The Arnold F. Baggins Foundation

Lori Pollan and Allan Bahn

Adam Leitman Bailey

Anne Baker

Pamela and Jesse Baker

Tara Baker

Ball Corporation

Leslie and Buck Balkind

Kristen and Jim Bandy

Shirley and John Bandy Jr.

Florence and Paul Banikiotes

Bank of America Charitable Fund

Justin Spitzer & Jenna Bans

Matthew D. Bantly

Daniel Barish

Mary Kathryn and Kyle Bass

Mickey Bass

Kathleen C. Bassi

Richard Bassuk

Dorothea and Anthony Bastian

Mario Batali

Bay Ridge Fuel Corp.

Char Beales

B.E.A.S.T., Inc.

Janel Becker

Constance and William Beemer

Dr. Holley A. Belch

Belkin Burden Wenig & Goldman, LLP

Deborah Bellen

Karen and Peter Belli

Andre Beltempo

Cecilia Benner

Raymond Benner

Michael J. Bensing

Cintra Bentley

Dana Berg

Bergen Anesthesia and Pain LLC

Shira and Loren Berger

Elizabeth Bergin

Marion and Stanley Bergman

Gretchen Bergstresser

Bruce H. Berlin

Pamela Bernhardt

Evelyn and William Bernstein

Best Buy Co, Inc.

Andrea Berry

Jo Anne and David Bescherer

Elaine R. Beyer

Kelly and Louis Biar

Jo-Anne Williams & Richard Bilotti

William Binger

James Blackorby

Thomas Blanchard

Betty and Ray Blanset

Emily Blavatnik

Mary Lou and Louis Bloede

Nancy and Randy Blue

Pierre Alain Blum

Edward and Susan Blumenfeld

Dr. Maxwell L. & Florence C. Blumenreich Foundation

BNY Mellon Community Partnership

Joanna Bomberg

Lisa Boom

Lucy and Robert Borcherding

Dorothy and Thomas Borders

Mike J. Borgerding

Ann Boston-Reamey

Linda and Norm Boyer

BP Foundation Inc.

Miriam and Steven Bram

Kenneth W. Brandes

Brenda K. Brantley

Braude Foundation

James H. Breay

David B. Breed

Michael Breton

Kathleen Brett

Bridgewater Associates, Inc.

Ms. Leila Kamal and Mr. Andrew Brockway

Roman Brodmann

Lynn and Dan Brody

Janice and Richard Brown

Toni Brown

Beatrice Bruce

Sandra and Peter Bruhn

Carol Bryan

Gary Buchanan

Beverly and James Buckley

Tracy and Paul Buckley

Christine Bulawa

Alyssa and Chad Burkhardt

Laura Kang and Paul Burkhead

Carolyn Greene and Donald Burns

Linko Burroughs

Eugenia and George Burylo

BWD Group LLC

Old World Industries

Patricia and Alfred Byrnes

Cain Brothers & Company, LLC

Carol S. Callahan

Barbara and Roger Calvert

Charles E. Campbell

The Ruth Camp Campbell Foundation

Lordes and Jose Campon

CanadaHelps

Maureen Cannon

Donald Cantway

Louis J. Capano Jr./III Family Foundation

Ann and Jeff Caplan

Jason Capone

CareOne at Teaneck

Ian T. Carnathan

Cheryl and Steven Carver

Stephanie and Mark Cartier

Casey Family Advised Fund

Robert Casiello

Eli Castro

Dawn and Rocky Caullwine

Carolyn and Louis Caviezel

Keri and Ryan Cavitt

Century Residential, LLC

Pamela Chan

Paul Chan

Robert T. Chang

Charitybuzz

Ruth and John Cherry

Michelle Chiu

Ginny and Don Chivas

Vicki Chung DMD, PC

Dr. and Mrs. Gary Cirilli

Claremore Club Inc.

Marlynn K. Clayton

Patricia Cleveland

Louise and Thomas Coffey

Bruce A. Cohen

David Cohen

The Frank and Lorna Colarusso Charitable Foundation

Joan and George F. Cole

The College of Wooster

Tracey and Adam Collins

Susan and John Collins

Columbus Realty Partners Ltd.

Command Web Missouri

Communities Foundation of Texas

Compulink Business Systems

Liz Bless and Rick Condon

Matthew Conroy

The Conway Foundation

John C. Conwell

Elizabeth and Arthur Cox

Judy and Bill Cox

Ruth Ann Cox

Cox Schepp Construction

Alice Crary

Mrs. Joan Creedon

Jeremy R. Crisup

Bruce and Alison Cunard

Mr. and Mrs. William J. Cunningham

Marco Currin

Cycling For Good, Inc.

D.B. Barker Estate

Art Dahl

Jane P. Dallam

Peter Daneker

Christine and James Dart

The David Family Foundation

Dorse Davis

Dwight W. Davis

Robert P. Davis

DaVita Total Renal Care, Inc.

Kathryn A, Keeler and Stuart M. de Haaff

Robert D’Eustachio

Decathalon Sports Club, Inc.

Suzanne C. Defrancis

David Deibel

James DeJesus

Michael L. De Jong

Robert Delitsky

Gilles Dellaert

Tina Demel

Denice DeQuinzio

Linda and Scott DeViney

The Di Cecco Family Foundation

Charles Diamond

Helen and Wayne Diamond

Jerry Diamondstein

Judith and Kenneth Dionne

Linda S. DiRocco

Patricia and Michael Dobosenski

Jody Dobrowski

Beverly Donnelley

Virginia and Glenn Doran

Jan and Joseph Dorsey

Gail Dowling

Karen and Christopher Downie

Steve J. Downs

Doyle Family Foundation Inc.

Patty and Howard Dubin

James M. DuBois

The DuBose Family Foundation

Margaret and Bruce Duff

Patrick and Mary Dunleavy

Dr. and Mrs. Paul P. Dunn

Dorothy Dupper

Mayer Dwek

Mary and Michael Dykema

Carole and David Ebner

Stanley Ebner

Joyce and Paul Eckel

EC Electrical Contractors, Inc.

Edison International

The Bernard A. Egan Foundation Inc

Nancy and Stephen Einhorn

Shelley and Steven Einhorn

Meg and John Eklund

Martin J. Elias

James Ellis

EMC Corporation

Kate Engelbrecht

Kevin Engelking

Mr. and Mrs. Richard England, Sr.

ePlus Technology Inc.

Ertman Family

Daisy Escalante

Grant Essex

Ethical Culture Fieldston School

Judith Evall

Bradford Evans

Laura and Edward Evans

Evans Tool & Die Inc.

The Evslin Family Foundation

ExactTarget, Inc.

$1,000 or more

continued from page 21

23 d

on

or

listing

Tom Ezaki

Robert A. Fahr

Fainbarg Family Foundation

Family Management Corporation

Family Marketing Inc.

Sim and Justin Farar

Stephen E. Farris

Fasnacht Family Foundation

Leslie and David Fastenberg

Brenda J. Favreau

Dennis Fay

Federal Insurance Company

Bunny and Sy Feigenbaum

Fidelity Brokerage Services LLC

Blair Thurman & Lara Ferb

Haley and Chris Ferraro

Javier Fernando

Heidi and Craig Feuerman

Jean and Richard Fiesinger

Dr. Gary Filerman

Guy Filippelli

Carol Fingerhut

First Long Island Investors, LLC

Doris Engelmann and Sieg Fischer

Brian K. Fiske

Peggy and Dick Fitzgerald

Susan and Norman Fixel

Charlotte and Jeremy Fletcher

Rayma and William Flint

Kirby and Glenn Floyd

The Ellen M. and Lawrence B. Floyd Foundation

Mary Ann and Ernest Forman

Rosemary Foot

Fortress Investment Group LLC

Tracey and L. Fowler

Karmen and Greg Fox

Fox Family Foundation

Linda and Sandy Frank

Maxine Frank

The Vanessa and Darryl Frank Foundation

Jill and Mark Freeman

Kipp and Bruce Freeman

The David A. D’Arcy and Judy A. Freitag Charitable Fund

Katherine Frekko

Sharon N. Freytag

Anne and Malcolm Friddell

Andrew and Brooke Friedman

Chelsea and Sam Fussell

Marc Fusillo

Gabriele Fitness and Performance

Frank Gabron

Bill Gaine

Allyson and Alan Galishoff

Bob and Lee Ann Galowich

Jane and Robert Gallagher

Patricia and Lawrence Gallaway

Marvin and Leslie Gans

Harry Garafolo

Helen and Edward Garrett

Richard Garthwait

Jennifer Gates

Julie and Daniel Gaver

Genentech

Generic Pharmaceutical Association

Genworth Foundation

Marilyn Gerber

Joan L. Germany

George Lindsey University of Northern Alabama

David Geyer

Lisa and Richard Giacco

Lee Becky Gilbert

Leslie and Cliff Gilbert-Lurie

Deborah and Donald Gill

Ina Gillis

Shirley Gleich

The Glen Oaks Philanthropic Fund

Elaine and Brenner Glickman

Paige and David Glickman

Mindy and Jeff Glickman

Lisanne and Howard Godnick

Jennifer Goff

Goldberg Rhapsody Foundation Inc.

Stuart Goldblatt

Lori and Brian Goler

Fred Goltz and Family

Anita Gomez-Palacio

Michael A. Gonzales

Robert Goodman

Marla Meg Gordon, Kornstein Veisz Wexler & Pollard, LLP

Richard J. Gorman

Elizabeth Gotlieb

Camille E. Granato

David Granoff

Alison and Andrew Gratz

Erica and Kenneth Grau

The Greater Cincinnati Foundation

Great Neck Family Foot Care

Pauline and Harold Greeban

Ted Green

Green Shield Canada

Kathleen and Ted Greenberg

Sheila Greenberg

The Martin B. Greenberg Foundation, Inc.

H. Peyton Green

Jillian Greene

Donald E. Greenway

Sharon Gregorcyk

Vicky Gregorcyk

Amy Grief

Edward W. Griffin Memorial Fund

Ray Griggs

David F. and Margaret T. Grohne Family Foundation

David Groom

Susie Scher and Allison Grover

Jean J. Gruber

Deborah and Allen Grubman

Tom Greunwald

Portia V. Gucanac

Arla G. Guild Estate

Helen Guishard

Charlotte and Larry Gustavson

Robert J. Hafel

Carol and Pat Hagan

Halperin Foundation

Rodney N. Hamilton

Jason Hammerman

Andrea and John Hampshire

Rita Wilson and Tom Hanks

Mary Jane Hanmaker

Charles E. Hansell

Hansen Family Foundation

Charles F. Harding

Ethel and Samuel Harmatz

Dr. Catherine Harmon-Toomer

David Alan Harris

Jan and Neil Harrison

Adele and Mark Hart, Jr.

Jeremiah T. Hart

Tony Hart

Nancy Hatch

Charles A. Hatstat

Nancy Hausman

June M. Haverly

Mark H. Hayes

Sharra L. Haynes

Martina Hayward

Judy and Robert Heiser

Robert H. Helfgott

Betty and Irwin Helford

Maddy and Lew Helfstein

Talia Helfstein

Heller Foundation

The Hermine and David Heller Foundation

Robert Helsgott

Bret Henkel

Richard E. Henriksen

Henry Family

Dolores M. Henze

Margie Herald

Thierry Herbert

Hercules Corp.

Debra Hernberg

Jim D. Herrgesell

Judy and Mark Herrmann

Adam Herz

Kathie S. Hetherington

Jo Hewell

Hewlett Associates LP

Hickory Springs Manufacturing Company

High Five Foundation

Irene F. Fleshner and David Hill

Joan and Eugene Hill III

Susan E. Hillery

Hilliard Farber & Co. Inc.

Werner Hinder

Linda and Mike Hinkle

The Hirsch Family

Warren Hirst

James A. Hitchcock

Judith E. Tschirgi and Steven J. Hoch

John and Nancy Hoey Charitable Gift Fund

Hogan & Hartson LLP

Greg Holden

Betty and Randolph Holder

Terry and Oliver Holler

Donald Holman

Cheryl K. Holt

Samuel and Hannah Holzman Trust

Deb and Jeff Horn

Mr. and Mrs. Ron Horton

Margaret and Richard Houlding

Jane and Peter Howard-Johnson

Pat and Shirley Howe Fund

HP Company Foundation

Barb and Jim Hoyt

Harriet F. Hubbard

Robert T. Huber

Leane and Gerald Huchital

Hudepohl Family

Derris and John Humphrey

Juanita C. Humphrey

Hurricane Restaurant

Hurst Foundation

Jill L. Hurwitz

Holly and Thomas Huth

John Hynansky

ICAP Services North America LLC

The IDT Charitable Foundation

Bonnie and Dudley Ince

ING

Sharyl and Roy Inlow

Jorge Iragorri

John S. Irish

Clifford W. Ishmael

J B S Limited

Lauren and Jeff Jackson

Alice Jacobs

Kathleen and Justin Jacobs

Ross Jagar

The Louis and Lucille Jakobson Family Charitable Foundation

Jay Fountain, PC

Mary Frances and John Jeffrey

Kathy M. Jenkins

Christopher Jensen

Bobbo Jetmundsen Foundation

Jewelry Fashions, Inc.

Alyssa and Barry Johnson

Carol Johnson

Carole and Frederick Johnson

Lisa and Lamar Johnson

Mr. and Mrs. Charles Johnson

Kara Johnston

Ryan, Peyton and Marshall Johnston

Elaine Joost

Steven R. Jordan

Dr. Rudolph & Mildred Joseph Foundation

Cheryl and Bob Josephson

Mike and Karen Justak

The staff of Kaled Management Corp.

Trudy and Albert Kallis

Aaron Kameyer

Tanya Kanchanagom

Heidi and Mickey Kantor

Carol G. Kaplan

Alan Karpman

Harold Karpman

Mildred Karpman

Ruth and Jess Karter

Howard Kaskel

Madhulika Katwala

Rachelle and David Katz

Dayle and Michael Katz

Margaret H. Kavalaris

Andrea L. Kay

Kathy Kazmierski

Gina Keenan-Heepke

continued on page 24

24 m

idye

ar r

epo

rt 2

011

| an

nu

al r

epo

rt 2

010

continued from page 23

Joanne and Ohilip Kehr

Joell and George Keim

Yvonne Kellar-Guenther

Eileen and John Kelly

Jed Kelly

Stanley Kemp

Irene R. and James M. Kerr

Pam and Archie Kerr

Barron U. Kidd

Mary Kilfoy

Becca and Craig S. Kinard

Dana and Richard Kind

Debbie J. Kinder

Kings Park Slope Inc.

Clarence T. Kipps

Gail and David Kirkwood

The Kenneth and Laurie Kissell Charitable Foundation

Brent Kittle

Lawrence Klainer

Leonard Kleiman

Edward M. Kleinschmidt

George Klett

Kevin Koch

John N. Kogan

Norman Konner

Mr. and Mrs. Ken Kopelman

Paul Korman

Missy Kotchey

Karen and Mark Koulogeorge

Kraus Family Foundation

Ranjit Kripalani

Lisa and Clyde Krogh

Averill Krom

Bridget and Elliot Krowe

Lawrence and Elizabeth Krulik Foundation

Beth and Williams Krumbein

Kristine and Patrick Krupa

Vilas B. Kuchinad

Dana L. Kueffner

L3 Organization Inc.

Walter D. La May

Alice L. Lainer

Joseph and Judy Lamastra

Carol Lambert

Mary Jo Lancione

Linda and Alan Landis

Michelle Landis

Constance Landmann

Eugene W. and Gloria Landy Family Foundation

Mary Lou and Bill Lange

Diane and Jerome Lapham

Patti and Thomas Larkins

Sue and Tom Larsen

Mary and Bob Larson

Pamela and Erik Larson

Jan and Fred Laughlin

Jamie and Curtis Launer

Laurel Conqueror 451

Blanche and Irving Laurie Foundation

Lynn Lavezzari

Joe Lavi

Ruppel Lee Family Foundation

Jill L. Leinbach

Daniel Lepanto

Judith and Michael Lesch

The Lester Foundation

Karin J. Leung

Levi Strauss Foundation

Howard Irene Levine Charitable Lead Trust

Lola J. Perniceiaro and Mark A. Levine

Ross D. Levine

Steven Levy

Brandon Lewis

Joseph C. Lewis

Tom Lewis

The Lewis Cousins

Peter Li

William Lidgett

Kelly and Steve Lilley

Janet and Fred Limbach

Karen and Mark Limbird

Pam Lindroos

Linda and Robert Livingston

Linda and Jerry Lockwood

Pamela and Arnold Loeb

Patrick Loftus-Hills

Antone and Deborah Lott

Billy Love

LoveToKnow Corp

Elaine Lowenthal

Lenore and Jack Lowenthal

Loyal Order of the Moose

Christopher Lozier

Benjamin P. Lucas

Michelle Luethy

Lynn H. Lullo

Lundbeck Inc.

The Donald C. and Norma (Klug-French) Allyn Fund of the Lutheran Community Foundation

Miriam Lutz

Michael and Louise Lynch Charitable Foundation, Inc.

Ellen R. Lynn

Jane and Marvin Maas

Mr. and Mrs. Macanliss

Scott Macklin

Sue and Doug Maclay

Macy’s Foundation

Amina Mahamadi

Kerri Mahan

Roxanne Majka

Make It Better

The Chris & Melody Malachowsky Family Foundation

Charles Malk

Kuldeep Malkani

Elizabeth A. Malone

John C. Malone

Janis and Lawrence Malone

Edward H. Mank Foundation

Mankwitz Family Foundation

Jeffrey Mann

Meryl and Michael Mann

Rick Manna

Mike and Sallie Manning

Will Manuel

Jeanne Markel

Markley Family Fund

Stanley Markofsky

Maryann C. Marquarot

Joanne Marqusee

Theresa Marran

Mars Foundation

Margaret and Robert Marshall

Nikki and Thomas Marshall

Dominick Martorelli

L. Mario Mascioli

Carol Massat

Marcia S. Massee

Martha and Jack Matloff

Susan Matthews

Joy and Tom Mauer

Robert W. May

Carol and Michael Mayes

Susan D. McBride

Sean McCabe

Docie and Larry McCormick

David McDonald

Phyllis McDonald

Marjorie & Richard McGahren Foundation

Pam and Rick McGauley

Linda and Tom McGee

Jane and Ray McGowan

Kristine and Tim McKay

Linda and Chris McKenney

Brendan McLaughlin

Scott McLaughlin

Samantha McLean

Michael B. McMahan

Mary and Joe Meaden

Mrs. Judy Meador

Christopher L. Medina

Mary Meeker

Anne M. Meister

Christopher Mellen Family Fund

Theresa Mellis

Frances Melone

Penny Mendelsohn

Amy and Jamie Mentgen

Courtney Menzel

Meridian Capital Group, LLC

Christi Meril

Annette Merle-Smith

Caryn Messinger

Andreas Meyer

John K. Michie

Fran L. Middleman

Milbrook Properties LTD

Susan Bartsch and Robert Mileti

Kristine and Brett Milkie

Brent D. Miller

Brian Miller

Charles Miller

Mitzi Miller

Joanne McElligott and Douglas Millett

The Mindich Family Foundation

The Mirapaul Foundation

Ritchie Bros. Auctioneers

Justin Mobley

Sallie and Mike Molina

Shelly and Frederick Molineux

Ron Moon

Nancy M. Moore

Shirlee B. Moore

Mariann and Carl Morales

Morgan Stanley Smith Barney Global Impact Funding Trust Inc.

The Moroze Family Fund

Susan Morrow

Motorola Foundation

Donald J. Moulin

MTV Networks

Kaushik Murali

Murdoch’s Ranch and Home Supply

Eleanor and Kevin Murphy

Maureen and John Murphy

Coo Murray

Thomas C. Muse

David Muskovitz

N & K Hawley

Laurel and David Nachman

David Nadeau

Michael Naumann

Sean F. Nazareth

Y & S Nazarian Family Foundation

Hector Negroni

Margaret and LeRoy Negus

Neiman Marcus

Marlene Nelson

Marlys A. Nelson

Richard P. and Faye Nespola Charitable Foundation

Carole J. Neuburger

George Neuman

Joan C. Niedfeldt

Alexandra and Michael Nolan

Ann and George Norris

Janet A. Norris

Virginia W. Norris

Norwood Runners Association

Noto Family Foundation

Lucio Noto

Amy and Chad Novak

Kristin and Michael Nugent

Ruby and Jack Obenauer

Robert C. Oberheide

Kathleen O’Brien

Thomas O’Brien

Gerald F. O’Connell

Patrick O’Connell

Jill O’Connor

James Offutt

John Oglesby

Kenney Oh

Kit and Roger Olen

Olympic Products LLC

Marlene E. Omeara & William F. Omeara Charitable Foundation

Madge and John Omps

Toni and Eric Oosting

Dara and Michael O’Reilly

Minna and Duncan Orrell-Jones

Gerald Osinoff

Mary Anne and Jim Ostrenga

Robert Ousterhout

Oxford Industries Foundation

Edmunds Ozolins

P & F Industries, Inc.

Lona and Don Packwood

Anna and Vincent Palazzolo

Craig S. Palonen

The Pampered Chef

Chester Panek

John J. Papandrea

Michael J. Pariano

Parkinson Education Program of Delaware

Cheryl Parker

Beverly T. Parry

The Partners at Kenyon & Kenyon LLP

$1,000 or more

25 d

on

or

listing

$1,000 or more

Richard Passen

Paul Pathak

Diane M. Pattee

Florence H. Pattee

Brian Patterson

Frances Paulsen

Brian Payne

Amy and Brook Payner

PCS Engineers

Anne and Jeffrey Pearl

Peisner, Girsch, Schaefer and Sfouggatakis

David Pelton

James J. Pelts

Faye Pender

Frank Perez

The Perlmutter Family Foundation

Joyce G. Pernin

Bruce Petersen

Jess R. Peterson

Sue Toeniskoetter and Dan Petree

John and Karen Petry

Verino Pettinaro

Diane and Jeffrey Pettus

Mary Lou Phippen

Robert I. Pianalto

Bill Pickler

Adele and Kenny Pincus

Peter Pique Embroidery LLC

Jane and Gerald Pittenger

PL Developments

Wendy and Bill Platt

Polimeni International, LLC

Carol A. Porter

June and Ian Postnikoff

James Powers

Claire, Hillary and Andrew Prins

Theodore S. Proxmire

Betty and Michael Prupas

Ann Purcell

Sandra and Darrel Quick

Dr. and Mrs. Bernard N. Raasch

The Rackman Foundation Inc.

Rainier Investment Management, Inc.

Lisa and Jim Ramsay

Rasmussen Foundation

Adam Ratica

Laura, Mark, Jess and Zach Ratner

Lynn and Harvey Ravner

Jeremy A. Rawitch

Sandra and Fred Rea

Recreational Equipment, Inc.

Kira and Ian Reed

ReedSmith

Regis Corp.

The Reichert Foundation

Jack Remnet

Kim J. Rendleman

Jackie and Cos Renzi

Kerri and Eric Reyer

Michael Rezak

Jill and Scott Rhea

Philip Rhodes

Jennifer Saul and Stephen Rich

Verna and Harry Richardson

Nancy Richardson

Richchar Inc.

Joseph Richter

The William L. Richter Family Foundation

Margaret E. Rick

Myrna and Norman Ricken

Jennifer Rihn

Riesterer & Schnell Inc.

RL Leaders LLC

Barbara and Craig Robbins

Susan and Robert Roberts

Kathryn A. Robertson

Edward Robinson

Sandy and Mark Robinson

Pam and Robert Robinson

Nicholas Roccanova

Laurie G. Rocha

Jack Rodin

Jane B. Roe

Daniel Roitman

Heidi Rose

J. William Rose

Meg and John Rosecky

Polly and William Rosen

Hope and Art Rosenberg

Ora Rosenberg

The Richard and Mary Rosenberg Charitable Foundation

Patti J. Rosenfield

Elana and Michael Rosman Fund

Cheryl and Bill Ross

Karen and Mark Rourke

Doris and Ray Rovero

The Rubel Family Foundation

Robert N. Rubin

Carleen Russell

Judy and Bill Russell

Law Offices of Anthony A. Russo, PLLC

Michele and John P. Russo

Saban Family Foundation

Saint Anthony Trust of Hartford

The Saint Paul Foundation

Susan G. Salerno

Kenneth R. Salling

Heather S. Sanders

William Sanders

Dave Sankey

Satterlee Stephens Burke and Burke LLP

David Satterthwaite

John Saunders

Vik and Margarita Sawhney

Linda Sawyer

Byrd Saylor

Bill Sayre/Merkle Response Management Group

Peter Scales

Antonia and Thomas Schell

Mr. and Mrs. Schelzi

Lila and Harry Schiffman

Richard and Theresa Schirripa

Kindell, Joe and Gavin Schoffner

School District of Jenkintown

Paul Schorin Tzedakah Fund

continued on page 28

2010 Matching Gift Companies

We are grateful to these companies for their generosity in matching or organizing employee gifts to MJFF, resulting in total giving of about $600,000 in 2010.

Abbott Laboratories, Employee Abbott Laboratories, Employee Giving CampaignAetna Foundation, Inc., Partners in Community GivingAK Steel FoundationAllstate Giving CampaignAmerican Express Foundation Company Employee Giving CampaignAmerica’s Charities, Inc.Ameriprise Financial Employee Gift Matching ProgramAmeriprise Financial Employee Giving CampaignAnheuser Busch, Inc.AT&T United Way Employee Giving CampaignBall CorporationBank of America United Way CampaignThe Baxter International Foundation

The Black & Decker CorporationBNY Mellon Community PartnershipBP Corporation North America, Inc.Bristol-Myers Squibb Company Employee Giving ProgramCardinal Health Foundation Inc.Chevron Texaco Humankind Matching Gift ProgramThe Clorox Company Foundation Employee Giving CampaignCoastal Georgia Combined Federal CampaignDell Direct Giving CampaignDeutsche Bank Americas Foundation Matching Gift ProgramEdison InternationalEnergizer Matching Gifts ProgramFederal Insurance CompanyGE Foundation

GenentechGenworth FoundationGive With LibertyGivingExpress Program from American ExpressGlaxoSmithKlineGlobal ImpactGoldman, Sachs & Co. Matching Gift ProgramGoogleGreenlight Capital, Inc.Halliburton Giving ChoicesHarris and Eliza Kempner FundHewlett PackardHP Company FoundationIBM CorporationIBM Employee Services CenterIllinois Tool Works FoundationIndependent Charities of AmericaINGJohnson & Johnson Family of Companies Matching Gifts Program

UBS Matching Gift ProgramUnited Way of Allegheny CountyUnited Way of Bartholomew County, IncUnited Way of Central and Northeastern ConnecticutUnited Way of Greater NashuaUnited Way of Greater TorontoUnited Way of NevadaUnited Way of New York CityUnited Way of Somerset CountyUnited Way of Southeastern PennsylvaniaUnited Way of the Bay AreaUnited Way of the National Capital AreaUnited Way of Tri-StateValley of the Sun United WayWells Fargo Community Support CampaignZiff Brothers Investments

JustGive.orgKaiser Permanente Community Giving CampaignKraft Foods Foundation Matching Gifts ProgramThe McGraw-Hill Companies Employee Giving CampaignMerck Partnership for GivingMicrosoft Matching Gifts ProgramMorgan StanleyMorgan Stanley c/o Cybergrants IncNestle FoundationNorthrop Grumman CorporationPfizer United Way CampaignThe Robert Wood Johnson FoundationSabre Holdings United Way CampaignSanofi-AventisSoutheastern Philadelphia Area Combined Federal Campaign

26 m

idye

ar r

epo

rt 2

011

| an

nu

al r

epo

rt 2

010

John DavisSusan M. DavisJames Nathan de HaaffClare DeBardelebenTina DellingerEarl DeutschDonald L. DeVaneDr. Dewey-DallasLoraine L. DeYampertVictor Di CeccoJohn R. DickinsonMorris DickmanSylvia DietlinPaul DiNicolaRudolph DiNunzioSherie DolinoyRebecca DollingerNedra DonnellyMary Elizabeth DowiczRobert J. DrummondStephen F. DunlapRichard D. EberThomas D. EbnerElizabeth EllweinJerry EngelbrechtThomas R. EnglishWilliam H. EricksonIrving EvallStanley FahnWilliam FahrRoger W. FavreauJohn FedeleCiro FerraroBruce FischerRichard FitzgeraldHumberto FloresBruce W. FoltzEsther M. FontecillaLawrence E. ForthoferGregory S. FowlerMichael J. FoxWilliam P. FranzeseNathan FreedmanMarvel E. FreelandAnne, Mac, Ginnie, Francie, and Robert FriddellRay FriedmanJeanne A. Frisbie

Louise BushArturo BussaniJohn J. ByrneJayne H. CairnsTheresa CalabroBarbara C. CalvertDuncan W. CampbellRoss M. CantyFloyd CardenThomas G. CarrBarbara CarverEvelyn CasmerPeggy CaullwineLee CerrellCalvin R. ChadwickSusan ChaffeeIrene CharetteElizabeth A. ChaseJosephine ChegiaMartin CherryWes ChristieDonald W. CiliottaThomas V. CliffordRichard CohenPat CollumRaymond T. CondonConley Rock ClevelandJim ConnorPanagiotitsia ConstantinouRobert H. CooperJohn CopelandHugh CorriganHugh Corrigan IIILucien J. CoteDonald CourtneyStuart CowlesEileen B. CoyneDick CreedonDon CrisupPatrick CrombieCharles T. CroyWilliam D. CrumpLuz CruzRonald M. CulpepperJudith A. CurtisArnold B. CushingLinwood CustalowRobert J. CvelbarVirginia J. Da RinMyron DaleAudrey O. Daley

Neal AcitoLisette L. AckerbergFabrizio AcquavivaEsther S. AdlerMargaret AlsupArnold R. AltshulerEleanor H. AnconaHolly S. AndersenJohn AndersonRobert AndersonRobert S. AndersonGeorge M. AndesGeorge H. ArcherAntonio ArmestoBarbara ArtetaLouis W. AstorinoMichael G. BadendieckJames BakerBenjamin H. BalkindDavid L. BalleeJames L. BanksElaine BarklWilliam B. BarnardRonald J. BaskinFrank M. BassPatricia M. BeauchampShakira BegumLinda L. BeiderShirley BelchJack BenaroyaChristine BentleyHoward D. BidwellRichard M. BlissCharles T. BobrinkKurt BorcherdingJane Boschert-ObitJames F. BoyleBarbara BrandesMartin BreckerJack BreedSusan B. BressmanAudrey BrickendenClaude M. BridgmanKeith BrooksWiley BuchananJames T. BuckleyClifford E. BullHerbert BurkhardtKermit O. Burrous

Walter FronstinHumberto GarciaJoseph A. GarraffaAbraham GaslowMarilyn J. GehlbachMelvin GerberJoseph A. GermanottaJack GieseckeRalph E. GiffinMichael GilesMary GishIra O. GlickAlbert B. GlickmanSheldon GoldsteinSharon M. GolubLogan M. GoreChris and Teresa GormanMargot GosenBill GrayThomas A. GreebanJacqueline GreenJoseph D. GreenfieldElliott S. GreenspanMatthew GreensteinCurtis L. GreenwayEdward W. GriffinGrace S. GriffithIda M. GriffithCharles GrinbergGlenn GruberPaul GustavsonGeorge GuzziMark L. HaberkornBarbara HamiltonThomas H. HankinsonClaude HarrisPeter HarrisonIsaac HartStanley HartThomas HartmanAlbert HarveyAriele HausnerGates HawnBonnie HaynesRonald P. HeatonJohn Joseph HeflinRobert C. HeiserMax P. HellerDaniel J. HelsdingenBuddy HerringMichelle Hespeler

Katherine H. HetzerCarroll S. HeydtNick HillNatalie HirshHarold B. HoffmanSidney A. HoffmanStanley HoffmanRobert HoldahlEllen J. HolmanJames R. HolmesChuong G. HongRichard E. HooverBetty J. HoytGabrielle HozierLucille H. HughesJohn R. HumphreyVictoria C. HurstWilliam H. HydeIn Memory of the 9/11 VictimsJozef IskraThomas JaaskelaBrian H. JacksonJack JacobsonLorraine R. JeffeWilliam JeffersMarian A. JohnsonMartha L. JohnsonFreeman P. JordanEd KalikowMarshall A. KaplanMolly R. KaplanJesse KarterRosalind KayMadeline V. KellyRobert C. KenneyJames KinderJohn Wesley KingMarlene G. KinseyMary KippsMary L. KissellNancy KittleGeraldine KleinschmidtFrederick G. KlemPatricia A. KlimalaJoan K. KonowitzJean KoprivaFrances KorstadBarbara KralyPhyllis Kravitz

2010 Tributees

The Michael J. Fox Foundation is grateful for the honor and memory gifts made in tribute to the following individuals and organizations in 2010.

27 d

on

or

listing

Thomas KurtzBarry LaidmanChristian D. LarsenRobert E. LarsonWallace LaudemanEarl LaughlinHarry LengerWilliam B. LeonardWilliam Leonard Sr.J. R. LevesqueHerbert R. LevineMurray LevittArnold LevyEdwin A. LevyFrank H. LewisMary LibarkaIra LiebermanReba LilleyBernard LippmanMarc LipschultzSybil E. LipschultzDeborah D. LongJames LortzWilliam S. LoveAmalia P. LucasJoe LulloJoseph W. LulloJames R. MacanlissMatthew J. MaguireRose MankosEugene MantheyElizabeth MarcisWilliam A. MarquarotThomas S. MarshallDonald MartinDominick MartorellliLasalle MayesRose T. McAllisterWilliam R. McBrideMitsuko McCandlishIda L. McClureKathy McCuneThomas D. McDowellPatricia A. McHaneyRebecca A. McKenzieMary Jane McMillinJulia L. MeadenJoel H. MeadorRichard L. MeirinkBernard T. MeisterScott MerilSam Metti

William H. MeyerDavid D. MillerDavid MillerIrven G. MillerLeo MillerEugene T. MoellerEileen MolinskiClaude MooreJerry MooreJ. Phillip MorleyJoseph F. MurphyJoseph MurphyLee D. MutterLee MutterIrwin NadelCharles NapravnikDaniel NapuckMaurice R. NazarethJohn NegliaJohn S. NelsonLyle M. NelsonMabel NelsonRon NelsonWerner NeuburgerJosephine NeumanDavid M. NewcombGloria NobleErrolyn D. NyswongerAnne O’BrienWilliam OusterhoutLisa OzolinsSamuel M. PageMary A. PalmerForestine ParrottJoseph C. PatteeJohn PattonDavid H. PeeryDaniel A. PepeFrank PerweilerDoris PetersonDieter PfingstBenjamin W. PinkRaymond E. PittmanWilliam T. PlattAlbert B. PolenAlbert PolenStephen M. PollanJane H. PrattRichard G. PrinsJoseph P. QuinnSkip QuinnKendall Raether

Elaine E. RalphGary L. RandallAlice L. RapisardaThomas B. RedingerKim J. RedlichJoan C. ReeseJoseph H. ReichDavid C. ReinhartValerie L. RemnetMargaret M. RheaPhilip RhoadsLeona RiceOrlen F. RiceGeorge E. RichArthur W. RickerDeborah RidelLouis M. RispoliCalvin RoachSherm RobbinsRobert H. RobertsonEli E. RobinsonJohn M. RocheCharles H. RoddIrving RoderSonya RodinBernard RoitmanMaya RomanoffMarion RoseZean RoseckyAnn RothAlan I. RothenbergBelle RothenbergRichie RothenbergFrieda E. RoweKathy J. RoweStanley RowlandJosef RueppPeter R. SaalmanRobert A. SalernoEvelyn SalkaEvencio SanchezLloyd SandelandsLewis J. SandersCarol B. SasnettJames W. SavardAnna SbarraViola ScalesElizabeth and Scott SchefrinLeon SchneiderDouglas C. Schoffner

Elaine W. SchusterRichard J. SchwartzPatricia SchwenkFrank G. SebekMiguel SerranoDeby ShaheenLeslie ShapiroStanley ShartleSusan SheltonGene ShepardNorman E. ShepardLloyd ShieldsJoanne ShipSherman P. ShriberGrace ShuM. Zainuddin SiddiqiEvelyn J. SimonRobert A. SimonHarold G. SkiemRobert H. SlaughterAlan E. SmithDenis C. SmithDiana V. SmithDick SmithDorothy M. SmithIra N. SmithPatrick SmithShelley M. SmithWayne SmithRonald SnyderBeth SobelJames D. SolesMary SouleAnne SpectorSteve SpencerRick SpierThe Staff of The Michael J. Fox FoundationThaddeus SteinMiny SteketeeDonald J. StewartVirginia C. StinsonRoger StollGiuliana StriglioAriele Hausner & Dan StrombergKelly M. StuartPatrick J. SullivanVera SunaWilliam SweetnamGlenn M. SwensonDr. S. Jerome Tamkin

Violet J. TaylorTeresa ThomasLois ThornbrughWarren H. TjaderAlbert O. TollMichael TomaskyJames TorokJohn E. TrabertJoseph TrosaCharlotte H. TrotterMarilyn TroxelRobert T. TuckerCharles E. TurkingtonMaximo UgarteLucille UlasovichJoseph M. VolkAnthony W. WalshHannah WassermannCarolyn S. WatsonJay L. WeidnerMargaret WelchLloyd J. WheelerWendy WhiteDonald A. WileyLinda WilliamsFrederick S. WintzerEarl WiseHermine WohlstadterMarty WolffWei T. WongFlorence L. WooleryKenneth WormserCarol A. WurtsHubert YauCharles H. YoungChristine YoungJames ZachZainulabadinLuis F. ZamoraJohn R. ZartmanGrandma Anna Zeltser

28 m

idye

ar r

epo

rt 2

011

| an

nu

al r

epo

rt 2

010

continued from page 25

The Jean and Thomas Schreiber Philanthropic Fund

Michael Schrimmer

Dave Schroeder

Schulman Family Foundation

Judith and John Schumacher

Marc Schumann

Mary and Richard Schuster

Teresa and Daniel Schwartz

Peter Schweitzer

Eileen R. Scott

Seabury Airline Planning Group

Seavest Inc.

Georgia L. Sebek

Sedgefield Interior Landscapes, Inc.

The Selkowitz Family Foundation

Dr. Laura Popper and Edward M. Shain

Marjory and Jeffrey Sharp

John F. Shea

Kevin Sheehan

Clifford A. Sheets

Matthew Shefler

Marti M. Shell

Pauline and Alex Shender

Patti and Martin Shenkman

Alethea Shepardson

Marilyn and Rex Sheppard

Michael Sherman

Richard Hogan & Carron Sherry Foundation Inc.

Maureen Clancy and Tom Shiftan

Catherine and Rony Shimony

Natalie and Kent Shinbach

John H. Ship

George C. Shipley

Jill and Sandy Sirulnick

Benjamin and Hanna Shlomi

Andy Shore

Shutterstock Images

Susanna G. Sickinger

The Sidewater Family Foundation

Aaron Siegel

Ben Sihota

Sills Foundation, Inc.

Fiona and Steven Silver

Barbara and Richard Silverman

Douglas Silverman

David Sims

Richard Singh

Jane and Steve Sinton

Cindy and Larry Sipkin

Diane Sipple-Cushing

Stoop-it.com

Aaron Sirulnick

Sanford Sirulnick

Bridget Sisson

Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates

Rita Sklar

Ruth and Michael Slade

Justin Slatky

Dorothy and Harvey Smith

Kim and Paul Smith

Maurice “Bo” Smith

Sherrill and Jonathan Smith

Will & Jada Smith Family Foundation

Judy and Bill Soles

Lynn Solky

Babs Soller and Randy Ross

Lisa, Jared, Jake, and Mitch Solomon

Gregory C. Soloway

Sound Sight Technologies Inc.

Southeastern Philadelphia Area Combined Federal Campaign

Spark Capital Partners LLC

Spectrum Associates

Lynne and Eric Spillman

Jo Ann and Ray Sporleder

Alice C. Stack Estate

Mr. and Mrs. Erwin P. Staller

Joan and Robert Staloch

Michael K. Stamper

Charles Stanfield

State Employees’ Community Campaign

Richard Stein

The Stein Family Foundation Inc

Antoinette Delruelle and Joshua Steiner

Anne and Casey Steketee

Drs. Susan and Robert Stephens

Janet Froelich and Richard Stepler

Sterling Pierce Company Incorporated

Liz and Emanuel Stern

Margaret P. Stevenson Foundation

Laura D. Stewart

Lisa and Wayne Stills

Rex Stith

Lawrence Storace

Jacquie L. Strauss

Marie Strebel

Ariele and Dan Stromberg

Harvey and Susan Stromberg

Strongsville Rotary Club

Martin J. Stuart

Susan Stuart

John D. Sturkie

Peggy Sturman

Michael T. Sullivan

Sulzberger Foundation Arthur Ochs Sulzberger Giving Fund

Sunset Capital 1, LLC

Support Parkinson’s Inc.

Donald Surdoval

Patt and Mark Suwyn

Suzanne and Don Svendson

Robert Sweet

Heather and Hayden Swofford

David Syn

Edward Taran Fund

David S. Tarica

Michele Tarica

Scott Tarter

Linda and David Taub

TAXI

John Teeger

David Tepperman

Benjamin C. Terry

Susan and Douglas Terry

Texas State Wireless Association

Jo & Alton Tew

A. Thakrar

Seow K. Thay

Lisa Thenell

Christine and Mark Thiel

Mary and Homer Thomas

Scott D. Thomas

Michele and William Thompson

Cary and Martha Thomson

Frank and Margaret Throssell Fund

Barton Tinapp

TKE Kappa Chapter

Frances B. Z. Tobriner

Susan and Ronald R. Tomasky

Gail Tomberg

Paula and Dave Tomlin

Mamie Tompkins

Tompkins, McGuire, Wachenfeld & Barry LLP

Catherine and Ned Topham Fund

Andrew Torok

Danielle Toscano

Total Restoration Inc.

May and Thomas Toy

Jean M. Trainor

Traub-Brittan Family Foundation

Donna J. Tromblee

David Trujillo

Savas Tsitiridis

Robert Tucker

Francine and Tim Turk

Candy Udell

Ueberroth Family Foundation

Nilda Ugarte

Universal City Studios LLLP

Marlies Urban

Victoria and Walter Van Den Burg

Loren K. Vanderslik

Jen Kurth

Michael G. VanMeter

Van Wagner Communications LLC

Patricia Vaughn

Vector Search Group

Nicole and Michael Vermut

Carey and Larry Vick

Victory Box Corp

Vistronix, Inc.

Leslie and Bill Vollbracht

Michele and Bradley Vollmer

Barry and Teri Volpert Foundation

Charles Vosmik

Florine and Jules Wachter

Debbie Wackel

The Wagner Family Foundation

Wagner-Braunsberg Family Foundation Inc.

The Morton & Lillian Waldfogel Charitable Foundation

Walgreens

Charlie Walker

Penny and John Wallerstein

Walmart Foundation

Suzanne Walsh

Timothy R. Walsh

James Wang

Jeff Ware

Sally and John Warjone

Warner Pacific Insurance Services, Inc.

David and Phyllis Warrick

Gayle F. Wasserman

Mindee Wasserman

Julie and JD Watumull

Lori and Denton Watumull

Wawa, Inc.

Zelda J. Waxenberg

Wear Your Music LLC

Adolf Wedel

Eliot and Beth Wegbreit

Margaret Weidner

Jean B. Weiner Foundation, Inc.

Laurie and Steven Weiner

The Roberta and Allan Weissglass Foundation

The Adam J. Weissman Foundation

Jeremy M. Weisstub

Weldon Gin Company

Jordana Well

Jane Wenner

Priscilla White

Glenn and Grace Whitecotten

Harry Whiteley

Carmel M. Whiteman

Ellsworth P. Whiteman

Mary and Rick Whiting

Margaret Whitton Charitable Fund

Michael Wiese

Robert E. Wilbur

Vern E. Williams

Wilmington Trust Company

Allen Wilson

Pete Wilson

Richard L. Wilson

Jonathan Wiseman

The Wittman Family Charitable Fund

Joel S. Wojnilower

Meredith Wolff

Shirley Y. Wong

Ms. Irene Wood

Glen Wright

Joanne and Donald Wright

Jennifer and David Wroan

Byron Wurdeman

William W. Wurts

Brooke and Brett Wyard

Dori and Paul Yang

Bettina and Kenneth Yau

Yellowstone Hardware Supply Corp.

Peggy Katz and Jim Young

Wanda and Donald Young

Julie A. Zach

Larry S. Zajdel

Ziff Brothers Investments

Daina Zivarts

ZogSports

$1,000 or more

29 d

on

or

listing

In 2010, over 1,160 Team Fox members collectively raised $3.9 million to support The Michael J. Fox Foundation’s mission to make Parkinson’s a thing of the past. These dedicated individuals continually inspire, motivate and surprise us with their passionate and creative efforts in pursuit of the cure.

Danielle Toscano ING NYC Marathon

The University of Virginia Pancakes for Parkinson’s

Dale Walz Parachuting for Parkinson’s

Eileen Werndorfer Brookfield Parkinson’s Run/Walk

Tim Wheeler Cole & Friends: An Elegant Evening

Anna Wistran Wolfe 4th Annual North Shore Walk for Parkinson’s Disease

Elizabeth Woodbury Annual Spring & Summer Style Show

Reid Young Plush Trust Fund 2010

Team Blei-well

Team City of Plattsburgh Half Marathon

Team Dynamite

Team Funner Runner

Team Lost Cause Motorcycle Riders

Team OBX CruZ for the Cure

Team Palmer Johnson Power Systems

Team Perfect 10

Team Put the Brakes on Parkinson’s

Team Ray Laethem

Team Shakin’ NOT Stirred

Team South Shore Walk Team

Team Spartan Boot Camps

$5,000 or more

Alice Aiello and Lori Demino ING NYC Marathon

Claire Allen Senior Recital

Lindsay Andras ING NYC Marathon

Rosemary Apeland ING NYC Marathon

Dance for a Cure Ciao Parkinson’s

Eagle Bridge Foundation SigChi Golf Weekend

Fred Fox ING NYC Marathon

Nicholas Frasso Help Hook The Cure Striped Bass Derby

Jayne GodfreyBACK FOR A CURE—Back to the Future Trilogy-25th Anniversary

Jason Helfstein NYC Triathlon

Karen and Marc Jaffe Shaking with Laughter

Jeffrey Joseph Fireworks for Fox

Alex Karpman Marathon Runner

Michael Kelly ING NYC Marathon

Heather Marsh ING NYC Marathon

Brian & Debbie McGrath ING NYC Marathon

Matthew Morrison Pickin’ for Parkinson’s Bluegrass BBQ

Beth Murray “Weekend Weather”

Party for Parkinson’s

Jennifer O’Farrell ING NYC Marathon

Gail Oliver The Seventh Annual Mrs. Mo Memorial Golf Tournament

Pinky’s Passion for a Parkinson’s Cure Pinky’s Passion for Fashion

Denise Pellegrino Rebels with a Cause

Pettinaro Family Griddle Team Delaware Pancakes for Parkinson’s

Amiel Sawdaye New England Parkinson’s Ride

James Schultice 2nd Annual Hacking for a Cure Golf Outing

Lisa and Alan Tice Arrowhead Open Golf Event

Oliver and Terry Holler To The Future: Transcontinental Mission

Hoobler Hustle Big D Marathon

Susan Kauffman Kickin’ Parkinson’s One Lap at a Time

Josephine Poehlmann 8th Annual Benefit in Memory of Tom Poehlmann

Rucker’s Candy LCPDA Golf Classic Fundraiser

Team Army of Change

$10,000 or more

Melanie Anderson ING NYC Marathon

Tina and Glenn Beattie Denny’s Pancakes for Parkinson’s

Peter Bleiberg Boston Marathon

Doug Bodel Levi Leipheimer’s King Ridge Gran Fondo

Debi Brooks Delaware Pancakes for Parkinson’s

Richard Broughton The Annual OBX CruZ for the Cure of Parkinson’s Disease

Curt Bunte Shake, Rattle and Roll

Elizabeth Camp ING NYC Marathon

Lynn Carlson Art Sale

Carol Constable Golf for Parkinson’s Benefit

Rosemary Beach Foundation, Inc. The Jim DelMauro Rosemary Run

Stephanie Desautels City of Plattsburgh Half Marathon

Tracey Earl Buckles and Spurs Gala

The Epstein Family Epstein Family Pancakes for Parkinson’s

$250,000 or more

Brian GrantShake It Till We Make It!

$100,000 or more

Danville D’Elegance Danville D’Elegance

Amar Kuchinad 2010 Continental Airlines 5th Avenue Mile & NYC Half Marathon

Team New England Parkinson’s Ride

Team Tips for Parkinson’s

$50,000 or more

Susan Bilotta Tips for Parkinson’s

Michael Costa The War on Parkinson’s Softball Game

Murphy to Manteo Murphy to Manteo

Wilkins Media Company Polo for Parkinson’s

Mary Anne Ostrenga Team Fox 5th Anniversary Garden Walk & Reception

The Woods Family New England Parkinson’s Ride

Team Delaware Pancakes for Parkinson’s

Team Ostrenga

Team Wilkins

$25,000 or more

Marian C. Bell Foundation P.A.R. for Parkinson’s Golf Event

Ted Bulthaup Back to the Future Reunion

Sonya Chodry ING NYC Marathon

Michael Dubin ING NYC Marathon

Debby and Lou Flancbaum Pars for Parkinson’s

Sharon and Roy Greif 6th Annual Friends of Parkinson’s Twilight Golf Outing

Florence Babbitt Thanks A “Tini”

Brian Baehr Spartan Boot Camps

Jill Bares Funding Parkinson’s Research One Laugh at a Time

Loren and Shira Berger ING NYC Marathon

Kathleen Beyer ING NYC Marathon

Sandi Bloomberg Book signings

Sam Brin ING NYC Marathon

John Buchanan ING NYC Marathon

Jim and Colleen Byrne Rock n Roll Mardi Gras 1/2 Marathon

John Cannon New England Parkinson’s Ride

John Carchedi Pick Up Your Feet 5K Run/Walk for Parkinson’s

Kyle Carlin Chicago Marathon

Joyce Chu ING NYC Marathon

Jody Culmone Team Fox Fundraiser

Team D-J-T Tips for Parkinson’s

Holly Deery Dick Deery Run for MSA

Margaret DeJesus ING NYC Marathon

Francis D’Haene ING NYC Marathon

Irv Edelman 2011 Green Bay Marathon

Jerry Ehlinger Chicago Marathon

Joe Erickson Team Fox Twin Cities Celebrity Classic — June 28, 2010

Kelly Ezickson London Marathon

Kurt FielderING NYC Marathon

$100,000 or more

$250,000 or more

$25,000 or more

$50,000 or more $10,000 or more

$5,000 or more

continued on page 30

30 m

idye

ar r

epo

rt 2

011

| an

nu

al r

epo

rt 2

010

continued from page 29

$5,000 or more

Sisters Fighting Parkinson’sTips for Parkinson’s

Linda Foresha Pirouettes for Parkinson’s

Daryl Frank ING NYC Marathon

Steven Ganin ING NYC Marathon

Alan Gettis Philadelphia Marathon

Bruce Gilbert Atlanta Concerts for Team Fox

Deborah Hagel Team Fox Dinner Party

Elizabeth Haines ING NYC Marathon

Robert Harmon and the Lake Ashton PD Outreach Group2nd Annual Golf for a Cure for Parkinson’s Disease

Christoph Hinder ING NYC Marathon

Kelly Holman ING NYC Marathon

Larry Howald Seven-In-Seven

Anders Hyde ING NYC Marathon

Ivy Family Griddle Team Delaware Pancakes for Parkinson’s

Karen Janos ING NYC Marathon

Lori Jawitz Parkinson’s Unity Walk

Alyssa Johnson and Barry Cohen Wet Dogs Calendar

Lori Johnston Optimism from Optometrists

Nathan Kirk ING NYC Marathon

David Kleinhandler ING NYC Marathon

Neil Korf Team Fox Fundraiser

Kathryn Kronick Finding A Cure for Parkinson

Ken Kubota ING NYC Marathon

Genevieve Kulaski Team Fox Chocolate Fest

Jeff Laethem ING NYC Marathon

Coughlin’s Law Tips for Parkinson’s

Natalie and Brad Lyons One America 500 Festival Mini-Marathon

Maura Mander ING NYC Marathon

Michael Maslar 2010 London Marathon

Dustin Matthews 5th Annual Hacker’s Cup Golf Tournament

Meghan McConnell 2011 London Marathon

Scott McGinnis 2010 London Marathon

Lisa McKinnon Rock the House; Find a Cure

Andrew McLean ING NYC Marathon

Victoria Ministri ING NYC Marathon

Matt Mitchell ING NYC Marathon

Matthew Okell Live Life Outdoors Ride Across Canada

Lenders On A Bender Tips for Parkinson’s

James Ostrenga ING NYC Marathon

Pamela Parker Parker’s Climb Mt. Kilimanjaro

Robert Parolin The Fox Open

Jennifer Patrickakos ING NYC Marathon

Sarah Rasmussen Annual Team Fox Golf Tournament

Preston Rau Dic-Wisco Farms Pars for Parkinson’s Golf Outing

Samantha Reid NYC Half Marathon

Tim Reid ING NYC Marathon

Unravel the Ribbon Charity Is Chic

Jason Robart Land’s End to John O’Groats Ride

Chris Braun ING NYC Marathon

Andrea Braxton ING NYC Marathon

Jacqueline Brown ING NYC Marathon

Rick Brown Philly Classic

Justin Budare Santa Barbara Half Marathon

Ellen Bushman Boston Marathon

Nicole Carino ING NYC Marathon

Mark Citron Students vs. Staff Charity Basketball Game

Philice Cohen ING NYC Marathon

Phil Comar Bridge to the Border Run

William Connelly ING NYC Marathon

Team Coolhands Tips for Parkinson’s

Mary Copeland Dragon Divas

Robert Cornell ING NYC Marathon

Geraldo Dannemann NYC Triathlon

David D’Arcy North Shore Century

Lev Dassin NYC Triathlon

Jared Paul DeLancey NYC Triathlon

Tyler Denison ING NYC Marathon

Amanda DePiro Haircuts for a Cause

Emily Diercks ING NYC Marathon

Siobhan Doherty ING NYC Marathon

Claire Dub ING NYC Marathon

Jay Dweck NYC Triathlon

Kris Dworkoski ING NYC Marathon

Andrew Ehrenberg Pogo for Parkinsons

Craig Erkus ING NYC Marathon

Tracey Segnit ING NYC Marathon

Ken Silver ING NYC Marathon

Madeleine Sinclair NYC Half-Marathon

Bill Smith Cross-country bike trip

ITSource Technology Corporate Donations

Team The Good Shepherds Tips for Parkinson’s

Gen Thompson and Adam Whiteley 2010 Chicago Marathon

University of Oregon James H. Warsaw Sports Marketing Center Jog 4 Jim

Matt Wilbur ING NYC Marathon

Daniel Wilkins ING NYC Marathon

Ron Winner ING NYC Marathon

Bev Young Beach Bash 2010

Team Fox Young Professionals Sunday Funday Brunch

Kathy Zweifel Party for Parkinson’s

Team North Texas

Team One Step Ahead

Team Parolin

Team Pirates In Paradise, Inc.

Team Stein

$2,500 or more

Alan Abrams ING NYC Marathon

Amanda Agulnick ING NYC Marathon

Matt Baehr First Annual Spartan Boot Camps “Sweat for the Cure!”

Jeffrey Blum ING NYC Marathon

Laura Bothwell Boston Marathon

Glyn Bough ING NYC Marathon

Vicki Bowlin Women’s Running Magazine Women’s Half Marathon

Barbara Etzel ING NYC Marathon

Nicholas Fera South Shore Walk

Karen Ford ING NYC Marathon

Aquinnah and Schuyler Fox 2foxes bracelets

Larry Frank 37th Annual California 10

Mark Gherty American Birkebeiner

David Gordon Boston Run to Remember Half Marathon

Stephen Gnojewski ING NYC Marathon

Raleigh Green V ING NYC Marathon

Kim Grubb ING NYC Marathon

Alyssa Harvey Chicago Marathon

Larry Herlan ING NYC Marathon

Tower Hill Gift of Service Week

Gerhard Hofer ING NYC Marathon

Fred Hoila ING NYC Marathon

Joy Hmielewski Out Run Parkinson’s

Alec Hochstein Cause I Like

Team Hoya Tips for Parkinson’s

Thomas Huber NYC Triathlon

Kieran Hughes Gifts in Lieu of Wedding Favors

Marybeth Hull ING NYC Marathon

Lynette ames ING NYC Marathon

Edmond Jang ING NYC Marathon

Christopher Jeffrey South Shore Walk

John Kaefer ING NYC Marathon

Ken Kapalowski We’re Going Back 25th Anniversary “Back To The Future” Event

$2,500 or more

31 d

on

or

listing

Natalie Karp Canyon Ranch Discounted Group Trips 2010

Shaun Keenan ING NYC Marathon

Annie Kelly Pounding the Pavement for Parkinson’s (2-mile fun walk)

Jennie Kelly ING NYC Marathon

Neil and Julie King ING NYC Marathon

Daniel Koh ING NYC Marathon

Michael Landau ING NYC Marathon

Renee Le Verrier The New England Parkinson’s Ride

Ingrid Leader Army of Change - Mt. Washington Climb

Jennifer Lee Griddle Team Delaware Pancakes for Parkinson’s

Tracy Lehnecker Medicus Foundation Fundraising

Al Levine T.P. 2010

Alissa Lifshitz NYC Triathlon

John Lohmann Playing Poker for the Fox

Patrick Love South Shore Walk

Madison Lyleroehr Meet Madison Jone Benefit CD

Jeff Margolies ING NYC Marathon

Raymond Markunas ING NYC Marathon

Francesca Marshall ING NYC Marathon

Chris Martusewicz Syracuse Half Ironman

George Martz’s Griddle Team Delaware Pancakes for Parkinson’s

Sarika Mathur My 12th Birthday Party

Adam Mayer ING NYC Marathon

Sean McDonald Cedar Springs Circle Annual Crawfish Boil

Tammy McPherson ING NYC Marathon

David Melvin ING NYC Marathon

Tina Middagh and Stacey Stout Chicago Marathon

Dori Miller Double English Channel Swim

Kristine Miller ING NYC Marathon

Brian Monk ING NYC Marathon

Morgan Morillo Party for a Cure

Kyle Mostransky ING NYC Marathon

Team N0-MUR-parkinson Tips for Parkinson’s

Joseph Nassirian South Shore Walk

Pawan Nelson ING NYC Marathon

Erin Nichols ING NYC Marathon

Tanya Niederhoff ING NYC Marathon

Ron Offutt The Five Boro Bike Tour

David Olk NYC Triathlon

Eric Olson ING NYC Marathon

Lauren Ostendorf ING NYC Marathon

Anne Ostrenga ING NYC Marathon

Stephanie Paddock NYC Half Marathon and NYC Triathlon

Rosemary Pepe Party to End Parkinson’s

Gaetan Pettigrew ING NYC Marathon

Kim Ready Cowtown Ultra Marathon

Jen Reed ING NYC Marathon

Allison Reese ING NYC Marathon

Ellen Reevas Chicago Marathon

Tia Roberts ING NYC Marathon

Barton Rose ING NYC Marathon

Daniel Rose Chicago Marathon

Heidi Rosenberg Palm Beaches Marathon

Samuel Ross Marine Corps Marathon

Running for Papa Nashville Country Music Marathon

Debbie Saavedra ING NYC Marathon

Thomas J. Sabourin ING NYC Marathon

David Sack ING NYC Marathon

Yuri Saldana ING NYC Marathon

Muriel Salimin ING NYC Marathon

Olivia Savard Pancakes for Parkinson’s/ My 14th Birthday

Lori Saviers 10 Mountains 10 Years: A Quest for the Cure

Scanlon Girls Griddle Team Delaware Pancakes for Parkinson’s

Barbara Schaeffer Charlotte Latin School’s Laps for Parkinson’s

Adam Schlesinger NYC Triathlon

Elizabeth Schorn ING NYC Marathon

Gwen Schroeder ING NYC Marathon

Lisa Schwab Chicago Marathon

Alex Scott 2nd Annual Friends of Team Fox Holiday Party

Moriah Scott ING NYC Marathon

Trey Sebus Chicago Marathon

Natalie Seeboth ING NYC Marathon

Megan Shackleton Boston Marathon

Bill Sherman Boston Marathon

Larissa Siegel Lara’s Birthday Bash

Chelsea Sigliano ING NYC Marathon

Phi Sigma Sigma Pancakes for Parkinson’s

Andrea Simon ING NYC Marathon

Alison Spain The Nation’s Triathlon

Steve Spencer 2nd Annual You Can’t Take It With You

Jennifer Stachel ING NYC Marathon

Aimee Steketee ING NYC Marathon

Barbara Stratton Bolder Boulder 10K

Shannon Stutzman Pedal Over Parkinsons

David Teitelbaum Knight-Teitelbaum Wedding

UBC The Sauder School of Business ING NYC Marathon

Cindy Theberge New England Parkinson’s Ride

Brian Thorne 2nd Annual Friends of Team Fox Holiday Party

Kelly Tinsley ING NYC Marathon

Alexander Touma ING NYC Marathon

David Trager London Marathon

Kari Travis Chicago Marathon

Michael Trower ING NYC Marathon

Mark Ulrich ING NYC Marathon

Liz Urban ING NYC Marathon

Kay Urban ING NYC Marathon

Alison Urkowitz Posing for Parkinson’s

Miles Wadley ING NYC Marathon

Ben Wexler Santa Barbara Half Marathon

Kate Whetman Pages for Parkinson’s Research

Rob Wilder ING NYC Marathon

David Wolff Chicago Marathon

Pam Wolpov ING NYC Marathon

Ryon Wolski Chicago Marathon

Colleen Wuebben Wuebben Family Skate-a-Thon

James Yen ING NYC Marathon

RichardZecchino Party Against Parkinson’s in America (PAPA)

Team Cause I Like

Team Green Foxtrotters

Team Half Marathon or Bust!

Team JAB

Team Lommel

Team Martin-O

Team Outrun Parkinson’s: A Race for Charlie

Team Parkinfest

Team RamRod

Team Shackleton

Team Trok

1,000 or more

Lizzie Abramson Team Ostrenga

Mike Achin Army of Change - Mt. Washington Climb

Laurie Allen 6 Miles for 60 Years

Andrew Allen Spinning For A Cure

Reema Alzoubi ING NYC Marathon

Joseph Anarella ING NYC Marathon

Justin Anderson Bronx Half Marathon

Jawn Angus Vancouver Marathon

Maureen Ashdown Pocket Change 4 Parkinson’s

Daryl Austin ING NYC Marathon

Team BAML Tips for Parkinson’s

Jessica Berta NYC Half Marathon

Judy Binder Judy Binder’s Raise for a Cure

Devon Bissell Chicago Half Marathon

$1,000 or more

continued on page 32

32 m

idye

ar r

epo

rt 2

011

| an

nu

al r

epo

rt 2

010

Bryan Blackorby Cooper River Bridge Run

Josh and Heather Blaine New England Parkinson’s Ride

Wilma Blanchard Schmerer A Cake for Parkinson’s

Beth Bolivar Los Angeles Marathon

Hayes Brown South Shore Walk

Tom Buckley NYC Triathlon

Beth Buzza Scott Tinley’s Adventures Road Triathlon

Bryon, Corey, and Em Cahill The Yuengling Shamrock Half Marathon & 8K

Christopher Callahan NYC Half Marathon

Frank Carmody, Jr. NYC Half Marathon

Dan Cerkan ING NYC Marathon

Danielle Chagnon Boston Marathon

AFE Chapter 151 1st Annual AFE Golf Charity Event

Ben Cherington New England Parkinson’s Ride

Jill Ciminillo Chicago Marathon

Janet Clough Team Fox Walk

Robert Cochrane Boys of Summer

Katie Congdon Chicago Marathon

Joseph Coscia Skyhawks Baseball Game — Portion of Proceeds

James Curtin Chicago Marathon

Heather Damron Santa Barbara Half Marathon

Morris Dascal The 5 Boro Bike Tour

Colin Darke ING NYC Marathon

Timothy Diamond ING NYC Marathon

Paul DiMarino Tough Mudder

Giang Doan ING NYC Marathon

Stacey Donley ING NYC Marathon

Sarah Driansky NYC Triathlon

Steven Durkee New England Parkinson’s Ride

Sarah Durrin Cox Providence Rhode Race - Half Marathon

David Eger Music for Parkinson’s Research Concert

John Ehlinger Chicago Marathon

Megan Faulkner ING NYC Marathon

Miranda Feldmann Army of Change — Mt. Washington Climb & NYC Marathon Cheering Section

Joseph Finney Chicago Marathon

Jayme Fogel NYC Half Marathon

Chris Frum Garrett County Gran Fondo

Easton Furman Easton Furman’s Bar Mitzvah

Liza Gaoiran ING NYC Marathon

Richard Garthwait Parkinfest

Benjamin Gascoigne Flag City Multisport Celebration

Lela Gascoigne ING NYC Marathon

Helen Gerry Homemade Purse Sales

Keith Gilbreath Chicago Marathon

Lionel Gonzalez Regulators Bike/Hiking Event

Ben Grady Country Music Half Marathon

Joseph Granat NYC Half Marathon

Julia Graves ING NYC Marathon

Wendy Graves Iron Man AZ

Wendy Grider ING NYC Marathon

Melissa Griffiths ING NYC Marathon

Erik Hagen Various Races throughout 2010

Stefanie Haines Ironman Wisconsin 2010

Hal Halvorsen Belvidere FOXTROT: Run Like a Fox In Belvidere 5K

Rebecca Harrison Project Action 2010

Molly Hensler Mercedes Marathon

Kristin Hoddy Chicago Marathon

Jeanette Hoffman Army of Change — Mt. Washington Climb

Tom Hoisington Yakima River Canyon Marathon

Billy Hoover Booneville Open, Cow Pasture Pool

Janie Hoover ING NYC Marathon

Michael Horst Chicago Marathon

Angela Hunt Chicago Marathon

Brian Hyde Army of Change — Mt. Washington

Larry Ice Parkinson’s Awareness Events

Dorit Ingber NYC Half Marathon

Anna-Marie Jaeschke Philadelphia Half Marathon

Lisa Jay Laguna Beach Dance Concert

Jennifer Johns Boston Marathon

Emily Johnson ING NYC Marathon

Kathleen Johnson Chicago Marathon

Jenny Kammer Chicago Marathon

Matthew Kaufman San Francisco Triathlon at Alcatraz

Ruth Kentor NYC Half Marathon

Nicholas Knuth NYC Half Marathon

Kenneth Kolaski Wear Jeans for Parkinson’s

Mona Kramer Monas & Winers Annual Wine Tour

Adam Krauseneck ING NYC Marathon

Pip Lambert ING NYC Marathon

Joanna Laubscher Chicago Marathon

Chelsea Leeper Indy Mini

Mara Lenhof Santa Barbara Half Marathon

Juan Leung Li NYC Half Marathon

Peter Liberto Redner’s Warehouse 1% Save -A-Tape Program

Eric Lommel ING NYC Marathon

Michelle Lorah NYC Half Marathon

Christopher Magoon Providence Rhode Race

Stephanie Martineau Pittsburgh Marathon

George Martz’s Griddle Team Delaware Pancakes for Parkinson’s

Robin Maxcy Maine Coast Half Marathon

Gary Mazzola Team Fox Fundraiser

Amy McAuliffe Cooper Chicago Marathon

Greg McGinnis Families & Friends of Parkinson’s Golf Tournament

Brendan McLaughlin ING NYC Marathon

Debra Millegan Santa Barbara Half Marathon

Katie Morgan ING NYC Marathon

Brett Murphy Philadelphia Half Marathon

Sydney Napp Sydney’s Bat Mitzvah

Shannon Neumann-Kilduff Out Bid Parkinson’s Art Auction

Maggie Newcomb Comedy for a Cause

Virginia Nokes Nokes Family Walk

Coye Nokes NYC Half Marathon

Lauren O’Hara ING NYC Marathon

Michele Olive NYC Half Marathon

Kristin Pall ING NYC Marathon

Amanda Palmer City of Plattsburgh Half Marathon

Berkeley County Parkinson’s Support Group Softball Game

Gaetano Parrinello ING NYC Marathon

Maribeth Pawlak ING NYC Marathon

Angela Pettinger Lake Health Distance Classic

Miriam Pizarro Army of Change — Mt. Washington

Larissa Raze Team Fox Fundraiser

Ryan Reynolds Team Fox Celebrity Chair

Amanda Richardson Amanda’s Birthday Party

Erin Riedel Santa Barbara Half Marathon

Dana Riess North Shore Century Ride

Carly Ringlespaugh, Rachel Efroymson and Julia Otteson Pennies for Parkinsons

Alysson Al Roberto Chicago Marathon

continued from page 31

$1,000 or more

33 d

on

or

listing

Binghamton University Foundation

BML Blackbird

Central Huron Secondary School

Charitybuzz

Michael Cotoia

Robert Fahr

Federal Aviation Administration

Fraternal Order of Eagles, Inc. Wayneboro Aerie No. 1758

Gregory Fowler

Hamden High School Hockey Alumni Association

Sheldon Hearst

Illinois Shotokan Booster Club

The Fitz and Adelaide Kauffmann Foundation

David Kiley

Preston L. Lowe

Mark Morris High School

The Mathis Group, Inc.

Missionfish-Polf

Eileen O’Neill

Parkinson’s Support Group of Rochester NY Inc.

Edward N. Robinson

Rockingham County Middle Schools

Michael Brodnax and Tony Schlarb

Lloyd Sheilds

Ira Smith

Texas Star Winery

Chandler Wright

2010 Community Fundraisers

We have made a concerted effort to accurately list all donors of significant contributions in 2010.

If your name is misspelled or missing from this report, please accept our apology and email the correct information to [email protected].

Terrin Trantham ING NYC Marathon

Bill Trewin Book sales, Driftwood Nature’s Sculpture

Sophia Tsai Georgetown to Idaho Springs Half Marathon

Mount Allison University Pancakes for Parkinson’s

Tom Unruh Chicago Marathon

Stephanie Valentinetti NYC Half Marathon

Timothy Vallilee Army of Change - Mt. Washington Climb

Alie Walker Whidbey Island Half Marathon

Danalea Warrick Chicago Marathon

Tom Warrick Chicago Marathon

Andy Weatherwax Poets for Parkinson’s Poetry Slam

Paschal and Laila Walsh Paz & Lai’s Wedding

David Weber ING NYC Marathon

Meg Weidner Cupcake Mission

Kenneth Weiser ING NYC Marathon

Willard Whitaker III Memphis St. Jude Marathon

Taylor Whittell Dublin Marathon

Sara Wichtendahl Chicago Marathon

Frances Wilkinson Trek Women’s Triathlon

Chris Wilson ING NYC Marathon

Rob Wilson ING NYC Marathon

Kimberly Wong NYC Half Marathon

Colleen Wuebben UNMC Skate-a-thon for Parkinson’s

Kyoko Yamamura ING NYC Marathon

John Robertson Chicago Marathon

Joao Rodrigues ING NYC Marathon

Carole Rogin Team Fox Fundraiser

Daniela Rosello Chicago Marathon

Kristen Rosentreter Chicago Marathon

Gerry Russell City of Plattsburgh Half Marathon

Lenni Sand Sister Chicks Jewelry

Alison Sarokhan Lobsterman Triathlon

Kristen Scappaticci Army of Change — Mt. Washington Climb

Reggie Scarpa Hartford Half Marathon

Patrick Schmitt ING NYC Marathon

Gary Schmitz Fallfest

Philip Scutts London Marathon

Jennifer Senske ING NYC Marathon

Marty Shenkman RV 4 The Cure

Kimberly Sherman New England Parkinson’s Ride

Roger Short Illinois Marathon

Bert Silva Mississauga Marathon

Kevin Snode Virginia Beach Rock ‘n’ Roll Half Marathon

Sara Spicker Sara’s Mitzvah Project

Kristin Sremba Bake Sales

Kerry Ann Sullivan Poker for Parkinson’s

Jacqueline Talarico Jewelry Sales

Susie Teal ING NYC Marathon

Mike Zegers Sporting Life 10K

Anthony Zeller Bay to Breakers

Team Alcatraz Triathlon

Team FoxyFics

Team Foxy Paws

Team Get after It for Linny!

Team Regulators

Team Running 4 Change

Team Sandi’s Striders

Team SPRINT — Super People Running to Investigate New Treatments

Team Together Let’s Fight

Team FoxyFics

Team Foxy Paws

Team Get after it for Linny!

Team Regulators

Team Running 4 Change

Team Sandi’s Striders

Team SPRINT — Super People Running to Investigate New Treatments

The Michael J. Fox Foundation is grateful to these community fundraisers whose events contributed $114,725 to our research agenda in 2010.

34 m

idye

ar r

epo

rt 2

011

| an

nu

al r

epo

rt 2

010

2010FinancialHighlights

In 2010, despite a challenging economy, MJFF

funded just under $50 million — our greatest

annual commitment to date — in research

targeted to speed treatment breakthroughs into

Parkinson’s patients’ hands. Yet we measure our

success not by dollars raised or spent, but by

scientific advances achieved.

We’re proud of what we’ve accomplished to

date. But we stand on the precipice of a new

day in Parkinson’s research, and we will never

be satisfied until we have attained our goal of

eradicating PD. As we look to the future, we

continue to refine our approach to solve the

problems and address the challenges standing in

the way of progress now.

One element of our strategy that will reliably not

change is our insistence on fiscal accountability

and transparency. These are core elements of

our organizational values, particularly in how we

spend supporters’ contributions. We’re proud of

our track record of efficiency: Since inception,

87 cents of every dollar spent has gone straight

to our research efforts. And we intentionally have

no endowment or excessive reserves. Every dollar

we raise is immediately deployed to advance

research with the best chance of leading to new

PD therapies and, ultimately, a cure.

The American Institute of Philanthropy rates

MJFF as an “A” in its list of Top-Rated charities,

based on MJFF’s organizational and financial

efficiency. In 2010 we were included for the

first time in the Chronicle of Philanthropy’s

“Philanthropy 400,” an annual ranking of the

400 U.S. charities that raise the most funds

from private sources. And our recent keynote at

the annual meeting of the Center for Effective

Philanthropy was the highest-rated conference

session in the organization’s history.

None of this would be possible without the

dedication of you, our longstanding friends and

supporters. Thank you for all you do.

2010 financial highlights follow. Full audited

financials and our most recent IRS Form 990s are

available at www.michaeljfox.org.

ForPDpatients,thosewhocareaboutthem,andanyonewhocaresdeeplyaboutputtingcharitabledollarstogooduse,thereasonstogivetoTheMichaelJ.FoxFoundationarenumerous.Inturbulenteconomictimes,weknowthatdonorsthinkhardabouttheir

charitablegivingandchoosetogivewheretheirdollarswillhavethegreatestimpact—ananalysisthatwebelievereinforcesoursupporters’commitmenttopartnerwithus.

35 Fin

anc

ial Hig

Hlig

Hts

“Despite the fact that many foundations and other nonprofits have struggled recently, MJFF has been able to consistently increase revenue year over year. With its inarguable success, the organization doesn’t seem like it should be looking to change things up any time soon. But it’s not resting on its laurels.” Fundraising Success magazine

Growing Investments in PD Research 2001-2010

0

10

20

30

40

50

Dollar amounts in millions. Does not include 2001 R21 awards in partnership with NIH.

2001 2002 2003 2004 2005 2006 2007 2008 2009 2010

$ 4

$ 14$ 15 $ 12

$ 17

$ 39

$ 24

$ 33

45

$ 49

55

$ 24

MJFF Efficiency 2000-2010

Research Program Activities 87%Administration 3%

Fundraising 9%

Research Program Activities 87%

Administration 3%

Fundraising 10%

36 m

idye

ar r

epo

rt 2

011

| an

nu

al r

epo

rt 2

010

As of December 31, 2010 2009

Assets Cash, cash equivalents and investments $ 49,495,371 $ 33,422,684Contributions receivable, net 28,467,039 35,401,415Prepaid expenses and other current assets 310,926 156,687Security deposits 33,061 33,061Inventory 22,872 28,036Property and equipment, net 337,060 278,893

Total assets $ 78,666,329 $ 69,320,776 Liabilities and Net Assets Liabilities: Accounts payable and accrued expenses $ 1,562,217 $ 1,713,780Grants payable, net 54,058,647 42,161,174Loan payable 1,000,196 1,000,196Interest payable 108,059 59,511Deferred rent 349,036 358,114

Total liabilities 57,078,155 45,292,775 Net Assets:

Unrestricted 4,179,853 2,345,986Temporarily restricted 17,408,321 21,682,015

Total net assets 21,588,174 24,028,001 Total liabilities and net assets $ 78,666,329 $ 69,320,776

Note: Investments are highly liquid

The Michael J. Fox Foundation for Parkinson’s Research

ConsolidatedStatementsofFinancialPosition

37 Fin

anc

ial Hig

Hlig

Hts

Year Ended December 31, 2010 2009

Unrestricted Temporarily Total Total Restricted

Public support and revenue: Contributions $ 25,032,666 $ 25,104,440 $ 50,137,106 $ 45,433,897Special events (net of direct benefit to donors of $358,540 and $269,950 in 2010 and 2009, respectively) 3,806,179 3,182,099 6,988,278 5,825,680Investment income 471,434 471,434 119,440Miscellaneous income 34,177 34,177 37,425

Total public support and revenue before release of restrictions 29,344,456 28,286,539 57,630,995 51,416,442

Net assets released from restrictions 32,560,233 (32,560,233) 0 0

Total public support and revenue 61,904,689 (4,273,694) 57,630,995 51,416,442 Expenses: Program services 54,545,702 54,545,702 39,153,137Management and general 1,387,556 1,387,556 1,263,737Fund-raising 4,137,564 4,137,564 3,951,379

Total expenses 60,070,822 60,070,822 44,368,253

Change in net assets 1,833,867 (4,273,694) (2,439,827) 7,048,189Net assets, beginning of year 2,345,986 21,682,015 24,028,001 16,979,812

Net assets, end of year $ 4,179,853 $ 17,408,321 $ 21,588,174 $ 24,028,001

The Michael J. Fox Foundation for Parkinson’s Research

ConsolidatedStatementsofActivitiesWith summarized financial information for 2009

38 m

idye

ar r

epo

rt 2

011

| an

nu

al r

epo

rt 2

010

2010 FinancialHighlights—Canada

As of December 31, 2010 2009

Assets Cash $ 441,531 $ 78,534 Contributions receivable — 250,000Due from The Michael J. Fox Foundation for Parkinson’s Research (USA) 169,459 102,175

Total assets $ 610,990 $ 430,709

Liabilities and Net Assets Liabilities: Grants payable $ 605,990 $ 425,709Accounts payable and accrued liabilities 5,000 5,000

Total liabilities $ 610,990 $ 430,709

The Michael J. Fox Foundation for Parkinson’s Research

StatementsofNetAssets

Sinceourlaunchin2000,TheMichaelJ.FoxFoundationhasreceivedasteadyoutpouringofCanadiansupport.CanadianresearchershavebeenactivelyinvolvedinourscientificagendasincetheearliestdaysandindividualsfromalloverthecountryhavesteppeduptopromoteParkinson’s

diseaseawarenessbyinvestinginourresearchorjoiningTeamFox.MJFFofficiallyregisteredasaCanadiancharityin2009.

39 Fin

anc

ial Hig

Hlig

Hts

The Michael J. Fox Foundation for Parkinson’s Research

StatementsofOperationsandNetAssets

Year Ended December 31, 2010 2009

Revenue Foundation donations $ — $ 250,000Donations 194,562 $ 184,941

Total revenue $ 194,562 $ 434,941

Expenses Research grant awards 180,281 $ 425,709Administration and other $ 14,281 9,232

$ 194,562 $ 434,941

Excess of revenue over expenses andnet assets, end of year $ — $ —

40 m

idye

ar r

epo

rt 2

011

| an

nu

al r

epo

rt 2

010

PROGRESS: The 2011 Midyear Report/2010 Annual Report of The Michael J. Fox Foundation for Parkinson’s Research is available in PDF format at www.michaeljfox.org.

Todd Sherer, PhDCEO

Michael J. FoxFounder

Deborah W. BrooksCo-Founder & Executive Vice Chairman

Editor/Writer:Holly BarkhymerVice President, Marketing and Communications

Designer: Susan Shaw

Illustrations by Column Five

Photo credits, pages 14-15:Photos 1, 2: Studio 1923/Jennifer and Jerome BragaPhoto 3: Courtesy Sonya ChodryPhotos 4, 5: StarTraks/Albert MichaelPhotos 6, 10, 12, 13: Ann Billingsley Photo 7: WireImage/Steven LovekinPhotos 8, 14: Elena OlivoPhoto 9: Courtesy Marian and Janet CloughPhoto 11: WireImage/Theo Wargo

The Michael J. Fox Foundation is a 501(c)3 nonprofit organization. © 2011 The Michael J. Fox Foundation for Parkinson’s Research

The Michael J. Fox Foundation gratefully acknowledges Bulkley Dunton for donating the high-quality McCoy Silk Cover and Text paper on which this annual report was printed, and Hearst Corporation for facilitating the donation.

Our gratitude to EarthColor, Inc., for printing this report below cost.

* Executive Committee

BoardofDirectorsGeorge E. Prescott Chairman

Woody Shackleton Vice Chairman

Holly S. Andersen, MD Eva Andersson-Dubin, MD Jon Brooks Barry J. Cohen Donny Deutsch David Einhorn Karen Finerman Nelle Fortenberry Michael J. Fox Albert B. Glickman David Golub Mark L. Hart III Skip Irving Ed Kalikow Kathleen Kennedy Edwin A. Levy Marc S. Lipschultz Douglas I. Ostrover Tracy Pollan Ryan Reynolds Frederick E. Rowe Lily Safra Curtis Schenker Fred G. Weiss

Founders’Council Lonnie and Muhammad AliSteven A. Cohen John A. Griffin Andrew S. Grove Katie H. Hood Jeffrey Katzenberg Morton M. Kondracke Nora McAniff Donna E. Shalala, PhD

LeadershipCouncilScott Schefrin Chairman

Claire Capello Sonya Chodry Dev Chodry Anne-Cecilie Engell Speyer Julie Fajgenbaum Richard Fitzgerald Lee Fixel Sean Goodrich Amar Kuchinad Justin Lepone Daisy Prince Josh Rosman Andrew T. Slabin

PatientCouncilEugenia Brin Carey Christensen David Eger, PhD David Iverson Jeff Keefer Soania Mathur, MD Thomas A. Picone, PhD Richie Rothenberg W.N. “Bill” Wilkins

ScientificAdvisoryBoardGene Johnson, PhDChief Scientific Advisor*

Alberto Ascherio, MD, DrPH Erwan Bezard, PhD Anders Björklund, MD, PhD Susan Bressman, MD Robert E. Burke, MD Angela Cenci-Nilsson, MD, PhD Marie-Françoise Chesselet, MD, PhD P. Jeffrey Conn, PhD Mark Cookson, PhD David Eidelberg, MD Matthew Farrer, PhD Charles (Chip) Gerfen, PhD Robert J. Gould, PhD J. Timothy Greenamyre, MD, PhD Franz F. Hefti, PhD* Etienne C. Hirsch, PhD Oleh Hornykiewicz, MD Ole Isacson, MD (Dr Med Sci) Joseph Jankovic, MD* Jennifer Johnston, PhD Jeffrey H. Kordower, PhD* J. William Langston, MD Frans Olof (Olle) Lindvall, MD, PhD Andres Lozano, MD, PhD Kenneth Marek, MD Eldad Melamed, MD Kalpana Merchant, PhD C. Warren Olanow, MD Bernard M. Ravina, MD, MS Peter H. Reinhart, PhD* Irene Hegeman Richard, MD* Ira Shoulson, MD Andrew Singleton, PhD* David G. Standaert, MD, PhD Dennis A. Steindler, PhD Caroline Tanner, MD, PhD, FAAN David Weiner, MD Michael Zigmond, PhD

* Executive Committee

Church Street Station P.O. Box 780 New York, NY 10008-0780 (800) 708-7644 www.michaeljfox.org

FINISH